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Summary 
This thesis introduces vinyl sulfonate terminated, star-shaped polyglycidols as a novel biomaterial for 
various kinds of applications. Polyglycidols, highly functional polymers with hydroxymethyl side 
groups, fulfill all structural prerequisites to replace poly(ethylene glycol)s in medical applications. 
Architecturally well defined polyglycidols with both linear and star-shaped structure and molecular 
weights up to 20 000 g mol-1 are prepared in an anionic polymerization procedure using ethoxyethyl 
glycidyl ether as monomer. Subsequently, these polymers are end-group functionalized by treatment 
with 2-chloroethylsulfonyl chloride leading to the formation of vinyl sulfonate terminated poly-
(ethoxyethyl glycidyl ether)s (VS-sPEEGEs). The acetal protecting group can be easily removed by 
treatment with hydrochloric acid to form vinyl sulfonate terminated polyglycidols (VS-sPGs) without 
affection of the functionality. 
Both vinyl sulfonate terminated polymers show high reactivity towards the formation of conjugates 
with amines. In organic solvents, VS-sPEEGE forms conjugates with various amines, e.g. amino acids, 
without the addition of any catalyst by a Michael-type addition reaction. Similarly, VS-sPG forms 
conjugates with different amines in slightly basic, aqueous solutions within a few minutes. The 
successful addition of amines to the polymers can be easily monitored by NMR spectroscopy. Due to 
the mild reaction conditions, the use of vinyl sulfonate terminated polymers for biomedical 
applications is promising and there usage in three different biomedical applications was investigated. 
Bulk hydrogels based on VS-sPG are prepared using poly(ethylene imine) (PEI), poly(allyl amine) 
(PAAm) or poly(L-lysine) (PLL) as polyamine. For all three polymers, stable hydrogels are achieved by 
addition reaction of VS-sPG with the corresponding polyamines leading to a crosslinked network. 
Hydrogels with up to 95 wt.% water content and good biocompatibility are obtained by variation of 
the polyamine as well as the polyamine:polyglycidol ratio. Depending on the pH value of the polymer 
solution, hydrogel formation is completed within 1-2 minutes. Using PLL as a biodegradable 
polyamine, biodegradable hydrogels are formed and can be further loaded with a fluorescent dye for 
investigation of their potential as carriers in drug delivery applications. Furthermore, bioactive 
compounds, e.g. enzymes, are entrapped into non-degradable hydrogels while maintaining their 
activity. Finally, hydrogel particles with diameters of approx. 5 to 10 µm, so-called microgels, are 
prepared using an inverse emulsion technique. 
Nanofibers based on sPEEGE are obtained by usage of the electrospinning process. As sPEEGE is a 
highly viscous but still liquid polymer, stable fibers can only be obtained by using a polymer blend 
containing up to 35 wt.% sPEEGE and poly(ε-caprolactone) as copolymer. By variation of the amount 
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of sPEEGE within the polymer blend as well as by adaption of the process parameters, highly 
hydrophilic and biocompatible polymer fibers with tremendously decreased protein adsorption are 
prepared. Surface reactive nanofibers are formed using polymer blends containing functionalized 
sPEEGE, e.g. vinyl sulfonate or alkyne terminated sPEEGE. Fibers formed from polymer blends 
containing VS-sPEEGE show high surface reactivity towards amines and can be biofunctionalized by 
simple immersion of the fiber mesh in an aqueous solution of the bioactive compound. By 
attachment of short peptide sequences, e.g. GRGDS, to the surface of the nanofiber meshes the 
interaction between cells and the nonwoven can be tailored towards their use in tissue engineering 
applications. 
Vinyl sulfonate terminated polymers can further be applied as surface coating. Both VS-sPEEGE and 
VS-sPG form stable polymer layers either by dip- or spin-coating from organic or aqueous solutions 
depending on the solubility of the polymers. Interestingly, high protein repelling properties are 
achieved using VS-sPEEGE, while coatings derived from VS-sPG still exhibit unspecific protein 
adsorption on their surface. This is astonishing as VS-sPG is more hydrophilic compared to VS-
sPEEGE. One potential explanation might be an incomplete coating, another one the possibility of 
hydrogen bonding between the polymer layers and the applied proteins. None the less, both types of 
polymers show high biocompatibility and no negative effects on the growth of cells are observed. 
Nonadhesive, antibacterial wound dressings are prepared by using the established hydrogel system 
based on isocyanate terminated star-shaped poly(ethylene oxide-stat-propylene oxide) (NCO-sP(EO-
stat-PO)). By application of nanoscopic layers of NCO-sP(EO-stat-PO) on the surface of commercial, 
cellulose based wound dressings, the adhesion force is reduced to 2 to 5 % compared to non-treated 
nonwovens. To support the wound healing process, the hydrogel layer can be further loaded with 
arginine. The growth of different cells, e.g. fibroblast, is up to three times faster upon contact with 
arginine loaded nonwovens compared to arginine-free samples. Additionally, nano-silver particles 
are embedded within the hydrogel layer reducing significantly the growth of E.coli. All modifications 
of the nonwovens are highly biocompatible and no toxic effects of the wound dressings are observed 
by in-vitro investigations. 
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Zusammenfassung 
Im Rahmen dieser Arbeit werden Vinylsulfonat-terminierte, sternförmige Polyglycidole als 
potentielles neues Biomaterial für verschiedene Anwendungen vorgestellt. Polyglycidole – 
hochfunktionale Polymere mit Hydroxymethyl Seitengruppen – erfüllen grundsätzlich alle 
strukturellen Anforderungen, Polyethylenglycole in medizinischen Anwendungen zu ersetzen. 
Mittel anionischer Polymerisation konnten strukturell hoch definierte, lineare und sternförmige 
Polyglycidole mit einem Molekulargewicht von bis zu 20,000 gmol-1 aus Ethoxyethlyglycidylether 
hergestellt werden. Durch Umsetzung mit 2-Chloroethylsulfonyl chlorid wurden diese Polymere in 
einem zweiten Schritt endgruppenfunktionalisiert. Die Acetal-Schutzgruppe konnte anschließend 
durch Umsetzung mit Salzsäure, ohne Verlust der Funktionalität abgespalten, werden. 
Vinylsulfonat-terminierte Polyglycidole zeigten eine hohe Reaktivität gegenüber Aminen und 
konnten in entsprechende Konjugate umgesetzt werden. In organischen Lösungsmitteln bilden 
Vinylsulfonat-terminierte Poly(ethoxyethylglycidylether) (VS-sPEEGE) in einer Michael-ähnlichen 
Additionsreaktion mit Aminen Konjugate ohne Katalysatorzusatz bei Raumtemperatur. Vinylsulfonat-
terminierte Polyglycidole (VS-sPG) bildet entsprechende Konjugate unter leicht basischen 
Bedingungen in wässrigen Lösungen. Die erfolgreiche Addition der Amine an die Polymere konnte 
mittels NMR-Spektroskopie nachgewiesen werden. Aufgrund der milden Reaktionsbedingungen 
erschien die Verwendungen von Vinylsulfonat-terminierten Polymeren in bio-medizinischen 
Anwendungen sehr erfolgsversprechend. Aufgrund dessen wurde ihr Einsatz in drei verschiedenen 
Anwendungsgebieten weiter untersucht.  
3D-Hydrogele basierend auf VS-sPG wurden durch Umsetzung mit den Polyaminen Polyethylenimin 
(PEI), Polyallylamin (PAAm) oder Poly(L-Lysin) (PLL) hergestellt. Durch Reaktion der Vinylsulfonat-
Endgruppen mit den Aminogruppen der Reaktionspartner konnten stabile, vernetzte Hydrogele 
hergestellt werden. Diese besaßen einen Wassergehalt von bis zu 95% sowie eine gute 
Biokompatibilität in Abhängigkeit des verwendeten Polyamines sowie des Einsatz-Verhältnisses 
zwischen Polyglycidol und Polyamine. Abhängig vom pH-Wert der Reaktionslösung war die Bildung 
der Hydrogele nach 1-2 Minuten abgeschlossen. Unter Verwendung von Poly(L-Lysin) als 
biodegradierbares Polymer konnten biodegradierbare Hydrogele hergestellt werden. Diese wurden 
zusätzlich mit einem Fluoreszenzfarbstoff beladen um ihr Potential für eine Langzeit-Medikamenten-
freisetzung zu untersuchen. Weiterhin konnten bioaktive Komponenten, z.B. Enzyme, unter 
Beibehaltung ihrer Aktivität in Hydrogele eingebunden werden. Zusätzlich wurden Hydrogelpartikel 
mit Durchmessern von 5-10 um durch Reaktion von VS-sPG und Polyaminen hergestellt.  
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Nanofasern basierend auf sPEEGE konnten mittels des Elektrospinning-Verfahrens aus einem Blend 
mit Polycaprolacton hergestellt werden. Durch Variation des sPEEGE-Gehaltes des Blends sowie der 
Prozessparameter konnten hydrophile und biokompatible Fasern mit einer verringerten 
Proteinadsoprtion hergestellt werden. Oberflächenreaktive Fasern wurden durch Verwendung von 
VS-sPEEGE hergestellt. Diese zeigen eine hohe Reaktivität gegenüber Aminen und können durch 
Kontakt mit einer wässrigen Lösung einer bioaktiven Komponente funktionalisiert werden. So kann 
die Interaktion eines Fasernetzes mit Zellen durch Anbindung einer Peptidsequenz, z.B. GRGDS, 
gezielt an eine Anwendung im Bereich Tissue Engineering angepasst werden. 
Vinylsulfonat-terminierte Polyglycidole können weiterhin als Oberflächenbeschichtung eingesetzt 
werden. Sowohl VS-sPEEGE als auch VS-sPG bilden aus wässrigen und organischen Lösungsmitteln 
stabile Polymerschichten mittels Spin- oder Dipcoating. Während durch die Verwendung von VS-
sPEEGE proteinabweisende Schichten erzeugt werden konnten, zeigen Schichten aus VS-sPG 
weiterhin eine deutliche, unspezifische Proteinadsorption. Dies lässt sich entweder auf eine 
unvollständige Beschichtung oder auf Wechselwirkungen zwischen den Proteinen und den freien 
Hydroxylgruppen des Polyglycidols zurückführen. Nichtsdestotrotz zeigen Beschichtungen beider 
Polymere eine hohe Biokompatibilität und keinerlei negativen Einfluss auf das Zellwachstum. 
Nichtadhäsive, antibakteriell-wirksame Wundauflagen wurden durch Verwendung des etablierten 
Hydrogelsystems auf Basis von Isocyanat-terminierten, sternförmigen Copolymeren aus 
Polyethylenglycol und –Propylenglycol hergestellt. Durch Aufbringen einer nanoskopsichen 
Hydrogelschicht auf die Fasern der kommerziellen, Cellulose-basierten Wundauflagen konnte deren 
Adhäsion auf der Oberfläche um bis zu 98% reduziert werden. Weiterhin konnten diese 
Wundauflagen zur Unterstützung der Wundheilung mit Arginine beladen werden, wodurch sich das 
Zellwachstum, z.B. der Fibroblasten, deutlich beschleunigte. Zusätzlich eingebettete Nanosilber-
partikel waren in der Lage, das Wachstum von E.coli Bakterien signifikant zu reduzieren. Alle 
Modifikationen der Wundauflagen waren biokompatibel und zeigten keinerlei toxische Effekte in 
verschiedenen in-vitro Untersuchungen. 
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Chapter 1: Introduction 
 
1.1 Biomaterials in modern medicine 
Today, most applications in modern medicine wouldn’t be possible without modern biomaterials. 
Biomaterials are present everywhere in modern medicine – in surgery, in dentistry, in ophthalmology 
and many more branches of the medicine.1 Some of the most prominent examples include the “drug 
eluting stent” (DES) used in cardio surgery, where polymeric biomaterials are present as thin coating 
on the surface of the metal stent responsible for the release of the drug. Another example is the use 
of alginate-based wound dressings for treatment of chronic or burn wounds.2  
Biomaterials can roughly be divided into two sub-sections: natural based and synthetic materials. 
While the properties of natural based materials, e.g. alginate, chitosan and hyaluronic acid, are 
difficult to adjust exactly to the requirements of the applications, synthetic biomaterials can be 
tailored to fulfill the desired specifications. Synthetic biomaterials are separated into different 
classes, including but not limited to metals, ceramics and polymers.1  
Polymeric materials have gained increasing interest during the last decades, especially due to the 
possibility of controlling the interaction between the interface of the implant and the biological 
system. During the last two decades, poly(ethylene glycol) (PEG) has been thoroughly investigated 
for the use in biomedical applications.3 Due to the high biocompatibility, combined with outstanding 
protein repelling properties, PEG is used for all kinds of different applications, e.g. drug delivery, 
coating of implant surfaces, sensor applications and tissue engineering.4-8  
None the less, further functionalization of PEG-based biomaterials is difficult as PEG does not exhibit 
any functional groups within the polymer chain. One possibility to overcome this problem is the 
change from linear to star-shaped architecture to increase the number of end groups, but still the 
potential of functionalization is limited. 
In contrast, polyglycidol (synonym with polyglycerol) (PG), is currently under investigation as it fulfills 
all structural prerequisites to replace PEG in biomedical applications. Additionally, PG offers free 
hydroxy groups within the polymer chain allowing the post-polymerization functionalization 
combined with high biocompatibility and therefore seems perfectly suitable as an alternative to the 
well-established PEG system.9, 10 
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Within this research, polyglycidols are investigated in relation of their potential for biomedical 
applications. Furthermore, the vinyl sulfonate group as a novel reactive group will be introduced 
allowing the preparation of amine-reactive polymers for the application in aqueous systems. 
 
1.2 Content of this thesis 
In the first part of this thesis, the synthesis of both linear and star-shaped vinyl sulfonate terminated 
polyglycidols will be described. Their potential for different biomedical applications will be 
investigated in the second part while in the third part the development of a novel, non-adhesive 
wound dressing will be described. 
Chapter 2 gives a brief overview about biomaterials in general, and their usage in different 
biomedical applications. 
Chapter 3 describes the synthesis of vinyl sulfonate terminated linear and star-shaped polyglycidols. 
Chapter 4 gives an overview about the unique reactivity of the functionalized polyglycidols in both 
organic and aqueous solutions. 
Chapter 5 presents the synthesis of both degradable and non-degradable hydrogels based on vinyl 
sulfonate terminated polyglycidols 
Chapter 6 is a study about the generation of nonwovens based on polyglycidol/poly(ε-caprolactone) 
blends for their use in tissue engineering applications. 
Chapter 7 shows the use of vinyl sulfonate terminated polyglycidols for surface coatings. 
Chapter 8 presents the development of non-adhesive, antibacterial wound dressings. 
 
Results presented in this thesis have been published and / or presented at national and international 
conferences. Results published in peer-reviewed articles are mentioned at the beginning of each 
respective chapter. For a detailed list of all publications and presentations, please see the appendix. 
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Chapter 2: Polyglycidols – A Novel Class of Biomaterials1 
 
2.1 Biomaterials 
While the term “Biomaterial” has already been introduced into research in the late 1960s followed 
by the formation of the Society for Biomaterials in the US in 1975, it took until 1987 for a widely 
accepted definition for the term “Biomaterial” by David F. Williams:1-3 
“A biomaterial is a nonviable material used in a (medical) device, intended to 
interact with biological systems.”  
Usually, materials referred to as biomaterials are used within or in direct contact to the human body. 
None the less, biomaterials can be used in other areas as well including but not limited to cell culture 
applications, protein handling or cell-silicon “biochips”.1  
The most important property of a material supposed to interact with a living system is its biocompa-
tibility, which has already been defined in the late 1980s, but has been recently redefined by Buddy 
D. Ratner to be more consistent with novel findings.2, 4 
“BIOCOMPATIBILITY: the ability of a material to locally trigger and guide non-
fibrotic wound healing, reconstruction and tissue integration.” 
Furthermore, he introduced the term Biotolerability indicating “materials with the ability to reside in 
the body for a long term without only low degrees of inflammatory reactions”.4 
Both synthetic as well as natural materials are used in medicine for various applications, e.g. artificial 
hip joints, dental implants or substitute heart valves. In addition to metal or ceramic biomaterials, 
different polymers used as implant materials have gained raising interest especially during the last 
decade. Most of these polymers, e.g. poly(methyl methacrylate) (PMMA), polyethylene (PE), 
poly(dimethyl siloxane) (PDMS) or polytetrafluoroethylene (PTFE) can be considered as biocom-
patible or biotolerable as they do not induce inflammation reactions or produce toxic degradation 
products. None the less, they are limited in their use due to uncontrolled protein adhesion on the 
surface. Within seconds to minutes, most artificial surfaces exposed to a living system will be covered 
with a monolayer of proteins followed immediately by cell adhesion which might led to blood 
clotting, inflammation reactions or other potential life threatening drawbacks.1 Most cells interact 
                                                          
1
 Parts of this chapter have been published in the review article: 
C. Stein, C. Püttmann, D. Haamann, M. Möller, D. Klee, S. Barth, The role of SNAP-tag in technical approaches, 
Current Pharmaceutical Design 2013, 19, 5449-5456. 
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with surface-adsorbed proteins rather than the material interface.5 Therefore, the biocompatibility of 
most used materials strongly depends on their protein repelling properties. 
Due to their specific structure, proteins, composed of ionic, dipolar, hydrophilic and hydrophobic 
amino acids, are able to undergo many different interactions with an artificial interface. As the 
kinetics of the protein adsorption strongly depends on the type of protein, no further kinetic studies 
will be addressed here.6, 7 In most cases, the adsorption of proteins on interfaces is dominated by 
hydrophobic interactions between the surface and the hydrophobic domains of the protein.8, 9 
Additionally, proteins absorb on surfaces via electrostatic interaction which strongly depends on the 
overall charge of the applied protein.10  
As most synthetic polymers are hydrophobic, they show high protein adsorption on their surfaces. In 
general, surface modifications with protein repelling properties have to be hydrophilic, uncharged 
and flexible. None the less, the hydrophilicity of a surface does not correspond directly with their 
protein repelling properties as hydrogen donor groups appears to be an additional key element in 
protein adsorption. As shown by Ostuni et al., surfaces with strong protein repelling properties 
generally exhibit four different properties on the molecular level: (i) hydrophilicity, (ii) availability of 
hydrogen-bond acceptors, (iii) no hydrogen-bond donors and (iv) a neutral electrical charge.11, 12 
Several natural and synthetic polymers fulfill these requirements and are currently used for the 
generation of protein repelling materials, e.g. poly(hydroxyethyl methacrylate), poly(acryl amide), 
poly(N,N-dimethylacrylamide), dextran and poly(ethylene glycol) (PEG, synonym to poly(ethylene 
oxide), PEO). 
Nowadays, PEG is widely used in all kinds of biomedical applications, e.g. for surface coatings, as 
scaffolds for tissue engineering or for the production of polymer-drug conjugates, so called 
PEGylation, due to its high biocompatibility.13-18 PEG exhibit excellent protein repelling properties as 
a result of its non-charged nature, its hydrophilicity and as there are no hydrogen donors present 
within the polymer chain as shown in Figure 2-1.  
 
Figure 2-1: Molecular structure of the polymer backbone of PEG. 
For high molecular weight PEG, the “steric repulsion” model has been found giving a theoretical 
explanation for the high protein repelling properties.19, 20 Besides hydrophilicity, high grafting 
densities are necessary to achieve protein repelling surfaces.16, 21 Furthermore, it has been shown 
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both theoretically and experimentally that branched polymer structures are superior for prevention 
of unspecific protein adsorption.22, 23 
During the last years, a novel hydrogel system based on an isocyanate terminated, six arm star-
shaped copolymer of poly(ethylene oxide) and poly(propylene oxide) (NCO-sP(EO-stat-PO), has been 
widely used for the generation of non-fouling surfaces.24-26 Due to self-condensing of these pre-
polymers after the coating procedure by formation of an urea group, dense networks with superior 
protein repelling properties are achieved as shown in Figure 2-2.16, 24 
 
Figure 2-2: Schematic comparison of (a, b) grafted high molecular weight multiarm star PEO, (c) grafted linear PEO and (d) 
grafted and intromolecularly cross-linked six-armed star PEO on a surface.
27 
(Reprinted with permission from Gasteier et al., 
Macromolecular Bioscience 2007, 7, 1010-1023. Copyright 2007 John Wiley and Sons) 
Furthermore, these polymer layers can be functionalized on the surface with bioactive compounds 
which allows specific cell adhesion, printing of nanostructures or the generation of antimicrobial 
surfaces.27-29 
During the last years, this system has been transferred for the use in other biomedical applications, 
e.g. as scaffolds for guided cell growth. Klinkhammer et al. recently showed the usage of NCO-sP(EO-
stat-PO) in combination with poly(ε-caprolactone) for the preparation of electrospun nanofibers for 
neuronal cell guidance.17 Grafahrend et al. showed a related approach using a combination of 
poly(lactid acid) and NCO-sP(EO-stat-PO).18 
PEG was introduced as a biomaterial more than twenty years ago and is nowadays established not 
only in academic research, but in industry for many different applications as well. None the less, PEG 
as a polymer without any functional groups within the backbone can only be functionalized at the 
end group limiting post-polymerization modifications drastically. To overcome this limitation, new 
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polymers with comparable properties but increased functionality are currently under investigation. 
Polyglycidol (PG) fulfills all structural prerequisites to replace PEG in different biomedical 
applications. 
2.2 Polyglycidol 
Polyglycidol (synonym with polyglycerol) (PG) has gained raising interest during the last years due to 
its unique functionality. In contrast to biopolymers like polysaccharides, most synthetic polymers 
have no functional groups attached to the polymer chain. Polyglycidol and its derivates with hydroxy 
side groups offer a broad range of potential applications due to their high functionality, 
biocompatibility and solubility in aqueous media. Furthermore, biomimetic polymers based on PGs 
can be synthesized by attachment of building blocks to the highly functional PG backbone.30 
In general, glycidol can be polymerized by two different pathways leading to two different kinds of 
polyglycidol as shown in Figure 2-3: (i) ionic polymerization of unprotected glycidol leading to 
hyperbranched structures and (ii) protection of the hydroxy group followed by anionic 
polymerization leading to linear or star-shaped structures depending on the applied initiator. 
 
Figure 2-3: Reaction pathways for the synthesis of polyglycidols. (pg = protecting group) 
Various groups have studied the ionic polymerization of glycidol leading to hyperbranched polymer 
structures. In the 1960s, glycidol was polymerized using a variety of bases as initiator showing a 
higher reactivity of glycidol compared to propylene oxide.31 The obtained hyperbranched structure 
was further investigated showing a rearrangement process during the polymerization procedure.32 
Later, the cationic polymerization of glycidol was reported proving the coexistence of both an 
activated monomer and an activated chain end mechanism.33 Due to the uncontrolled branching of 
the resulting polymer during the polymerization process, synthesis of hyperbranched PGs with 
defined architecture has been challenging. Approximately 10 years ago , Sunder et al. reported a 
method based on the fast proton exchange equilibrium for the controlled polymerization of glycidol 
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leading to hyperbranched structures.34-37 The obtained polyglycidols showed high biocompatibility, 
no toxic side effects and are generally recognized as safe by FDA.38, 39 Therefore, the use of 
hyperbranched PGs for various medical applications has been investigated during the last decades, 
including but not limited to their use as blood-plasma expanders, for the encapsulation of cells, as 
wound dressings, as scaffolds for tissue engineering, for surface coatings and various other 
applications.39-44 An excellent and comprehensive review has recently been published showing the 
broad field of potential biomedical applications.45 
None the less, polyglycidols with hyperbranched structures are limited to polydispersities of approx. 
1.3 to 1.5. To obtain architecturally well controlled PG, the hydroxy group of the glycidol monomer 
has to be protected with a suitable protecting group. Furthermore, the architecture of the polymer 
can be tailored by selection of the initiator.30 
Mostly, ethoxyethyl glycidyl ether (EEGE) has been used for the protection of the hydroxy group 
since it can be easily removed under acidic conditions. Several groups have studied the anionic 
polymerization of EEGE followed by removal of the acetal protecting group towards the synthesis of 
linear PG.46-51 In addition to EEGE, tert.-butyl glycidyl ether (tBGE) and allyl glycidyl ether (AGE) are 
frequently used for the synthesis of defined PG (Figure 2-4). 
 
Figure 2-4: Frequently used monomers for the synthesis of protected polyglycidols. 
Block and random copolymers from EEGE, tBGE and AGE monomer were prepared by anionic 
polymerization. The different protecting groups of the obtained polymers can be selectively removed 
and therefore allow the control of the functionalization degree within the polymer chain.52 
Furthermore, star-shaped PGs were synthesized using di- or multifunctional initiators, e.g. di-
trimethylolpropane, leading to polymers with defined architecture. Analysis of both linear and star-
shaped polyglycidols showed no significant difference with respect to the molecular weight and 
polydispersity index.30, 47 In general, PEEGE with narrow molecular weight distribution can be 
produced in a controlled manner up to a molecular weight of approx. 30 000 g mol-1.30 It has been 
shown that chain transfer to the monomer is one possible inhibition mechanism of the synthesis of 
higher molecular weight polymer.53 
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The functionalization of natural hydroxy-functional polymers, e.g. cellulose or starch, by polymer 
analogous reactions has been widely described. Similar to these derivatives, the hydroxy side group 
of polyglycidol could be functionalized either directly by condensation reaction or via the formation 
of poly(phenoxycarbonyl glycidol) as an activated carbonate.30, 54 As an example, propargyl side 
groups were introduced to the polyglycidol polymer allowing further functionalization by so-called 
“click”-reactions.52 Another possibility for the post-polymerization functionalization of polyglycidol is 
the chemically or enzymatically grafting of polymers from polyglycidol backbones leading to mole-
cular bottle brushes.47, 55, 56 An excellent and comprehensive review concerning the synthesis as well 
as post-polymerization functionalization of linear polyglycidols has been published in 2009.30 
Similar to the previously discussed hyperbranched polyglycidols, linear polyglycidols showed no 
toxicity and high biocompatibility.38 The metabolism of both polyglycidol and its fatty ester derivates 
has been studied in detail showing that the fatty esters were hydrolyzed and absorbed within the 
body while the remaining polyglycidol backbone was not catabolized and excreted rapidly in the 
urine.57 A series of studies concerning the biocompatibility of polyglycerol polyricinoleate (PGPR), an 
ester derivate of PG used as food additive, in rat and mice models provided high biocompatibility as 
well.58-60 Additionally, a human study about the consumption of PGPR showed no adverse effects in 
man.61 
Despite the superior controllability of linear polyglycidols compared with hyperbranched ones, 
combined with similar biocompatibility, only few reports have yet been published using linear 
polyglycidols in biomedical applications. As one of the few examples, Theiler et al. reported the 
synthesis of antibacterial polymers based on glycidol and THF.62 Furthermore, poly(ether ester) 
conjugates with enhanced biodegradability based on polyglycidol and poly(ε-caprolactone) or poly(L-
lactide) have been reported for the potential use in implants, for drug delivery applications or in 
tissue enginnering.63 
  
2.3 Bulk Hydrogels for Biomedical Applications 
Since the first report of the use of hydrogels for biomedical applications in 1960, hydrogels both on 
the macro- and nanoscale became an irreplaceable and fundamental part in biomedical research.64-66 
While the use of different hydrogels as surface coatings for the control of the biointerface will be 
described later, this section of this chapter will focus on the synthesis of hydrogels for drug delivery 
applications. 
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Hydrogels, cross-linked networks of hydrophilic polymers, have a high affinity for water while being 
prevented from dissolving by their cross-linked network. Depending on the type of crosslinking, 
hydrogels can be separated into stable (chemical cross-linked) or reversible (physically cross-linked) 
hydrogels. While reversible hydrogels can be degraded without affection of the chemical structure, 
e.g. by cleavage of ionic interactions, chemically cross-linked hydrogels can degrade by cleavage of 
covalent bonds. An example for a physically cross-linked hydrogel by ionic interactions is given in 
Figure 2-5. 
 
Figure 2-5: Schematic of methods for formation of two types of ionic hydrogels. An example of ionotropic hydrogel is 
calcium alginate, and an example of an polyionic hydrogel is a complex of alginic acid and polylysine.
65 
(Reprinted with 
permission from Hofman, A.S. Advanced Drug Delivery Reviews 2002, 54, 3-12. Copyright 2002 Elsevier) 
 
Due to their high water content, most hydrogels are highly biocompatible, offer a high porosity and 
show minimal tendency to adsorb proteins from body fluids due to their low interfacial tension. In 
general, hydrogels can be divided into three different classes: (i) natural hydrogels, (ii) synthetic 
hydrogels and (iii) biohybrid hydrogels, a combination thereof.64 
Hydrogels based on natural materials can be derived from polymers like collagen, hyaluronic acid, 
fibrin, alginate, agarose or chitosan.67, 68 As natural hydrogels are based on natural occurring 
polymers, they often show excellent biocompatibility and low toxicity and therefore are used in 
different kinds on biomedical applications, e.g. in drug delivery and for tissue engineering.64, 67-69 
None the less, biologically-derived hydrogels often lack of reproducibility and mechanical stability as 
the natural polymer normally cannot be achieved in a well controlled manner. 
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In contrast, hydrogels with tailored properties, e.g. biodegradation, mechanical strength, and 
chemical and biological response, can be achieved by crosslinking of synthetic polymers, e.g. PEG, 
poly(hydroxyethyl methacrylate) (PHEMA) or poly(vinyl alcohol) (PVA).64 
PEG hydrogels are known to be non-toxic, non-immunogenic and are proved by FDA for various 
clinical uses. Furthermore, PEG is known to have strong protein repelling properties. Therefore, 
hydrogels based on PEG have been widely studied during the last years for all kind of different 
biomedical applications.64 The hydrogels can be prepared by a variety of crosslinking methods. PEG-
diacrylates were cross-linked by photopolymerization to form non-degradable hydrogels for drug 
delivery applications.70 This crosslinking reaction does not require harsh conditions and can therefore 
be used to form PEG hydrogels with encapsulated, living cells.71 Degradable peptide sequences can 
be included for the formation of biodegradable hydrogels.72 Temperature-responsive hydrogels were 
obtained by combination of poly(N-isoproylacryl amide) (PNIPAAm) and PEG via a Diels-Alder 
reaction.73 Such responsive hydrogels have gained raising interest as they can be used in analytic 
applications.74 Furthermore, PEG hydrogels can be formed by high-energy irradiation.75 
The third and most interesting group of hydrogels, so called biohybrid hydrogels, combines synthetic 
polymers with natural components, e.g. peptides, natural polymers or enzymes. By integration of 
biological compounds inside a hydrogel network, novel materials with outstanding properties can be 
synthesized. Especially for drug delivery applications, degradable hydrogels are necessary to allow 
the release of the loaded drug.76, 77 The synthesis of degradable, synthetic hydrogels can be 
challenging as most of the commonly used polymers are not biodegradable. Therefore, degradable 
cross-linkers have to be used, preferably without modification of the physical properties of the 
hydrogel. Additionally, potential toxic degradation products of the crosslinking agents can be a 
problem as well. Therefore, the use of PEG as synthetic polymers combined with nature-based 
components, e.g. peptide sequences or poly(amino acids), has been investigated in detail.78-82 
In 2003, the synthesis of vinyl sulfone terminated PEGs for the formation of PEG-based hydrogels via 
Michael-type addition reactions using peptide sequences as crosslinking agent has been described in 
detail.78 By variation of the peptide sequence, the properties of these hydrogels can be controlled 
and it has been shown that these hydrogels can be used for the repair of bone defects.79, 80 By 
introduction of cleavable peptide sequences, degradable hydrogels were achieved allowing the 
synthesis of proteolytically degradable hydrogel matrices for tissue engineering properties.81, 82 
As an alternative for the synthesis of degradable hydrogels, the use of poly(amino acids), e.g. 
polylysine or poly(γ-glutamic acid), has been investigated. Both polypeptides can be cross-linked 
either by irradiation or by treatment with organic crosslinking agents and could be degraded by 
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treatment with enzymes.83-87 Poly(γ-glutamic acid) can further be functionalized with taurine to form 
thiol-containing poly(γ-glutamic acid)-sulfonate, which further can be cross-linked via disulfide bond 
formation.88-90 Such polymers have shown to be useful for the construction of 3D-engineered tissues 
by hydrogel template approach.91 Biohybrid hydrogels were prepared by combination of PEG and 
poly(L-lysine) cross-linked via carbamate chemistry to form biodegradable hydrogels with the 
potential of neural stem cell differentiation.92 
As a most recent example, a biohybrid hydrogel based on PEG-diacrylate and a modified chitosan has 
been prepared by photopolymerization. While being highly biocompatible, this hydrogel shows 
strong antimicrobial properties combined with manageability due to the combination of the 
properties of the two components presenting an typical example of the advantageous possibilities of 
biohybrid hydrogel.93 
Within the last few years, the use of hydrogel particles with diameters within the micron- or 
submicron scale, so-called micro- and nanogels, have gained tremendous interest especially for drug 
delivery applications.94-96 Due to their large surface area, they offer the possibility for multivalent 
bioconjugation for the use as targeted drug carrier.96 Different pathways for the formation of both 
micro- and nanogels has been reported during the last years, including but not limited to 
photolithographic and micromolding methods, microfluidic, precipitation polymerization as well as 
several emulsion polymerization methods.95, 96 Especially precipitation polymerization has been 
widely established for the synthesis of microgels as the size of the obtained particles can be 
controlled in a broad range.97 In Figure 2-6, the formation of microgels by precipitation 
polymerization is shown schematically. 
 
Figure 2-6: Formation of microgels by precipitation polymerization.
97 
(Reprinted with permission from Pich, A; Richtering W. 
Advances in Polymer Science 2011, 234, 1-37. Copyright 2011 Springer) 
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A broad range of different microgels were prepared by precipitation polymerization, e.g. 
temperature-sensitive particles based on PNIPAAm or poly(N-vinylcaprolactam) (PVCL). An excellent 
and comprehensive overview about microgels prepared by precipitation reactions as well as their 
postmodification has recently be published by Pich and Richtering.97 
Additionally to the precipitation polymerization process, emulsion procedures have gained 
importance during the last years. In an inverse emulsion polymerization, aqueous droplets containing 
water-soluble monomers were stabilized in an organic phase and then polymerized by addition of a 
radical initiator or by photopolymerization. An example for microgels prepared by an inverse 
emulsion polymerization is shown in Figure 2-7.96 
 
Figure 2-7: Illustration of preparation for microgels of PEO-b-PPO-b-PEO via inverse emulsion polymerization.
96, 98 
(Reprinted with permission from Missirlis et al., Langmuir 2005, 21, 2605-2613. Copyright 2005 American Chemical Society) 
 
Apart from free radical polymerization within the micelles, the use of different addition reactions, 
e.g. disulfide bond formation or Michael-type addition, is possible for the formation of nano- and 
microgels.96, 99 The preparation of biocompatible and degradable hydrogels based on PEG and PG via 
disulfide bond formation has been reported. These particles showed no toxic effects and can 
effectively be cleaved inside a cell for the intracellular delivery of bioactive compounds.100 Using a 
different approach; non-degradable nanogels based on PG were prepared by a 2+3 Huisgen 
cycloaddition.101 
  
Chapter 2: Polyglycidols – A Novel Class of Biomaterials 
 
18 
2.4 Electrospinning 
Electrospinning as a facile method for the preparation of fibers in the sub-micron range has been 
used for various kinds of applications during the last decade, e.g. for filter and textile applications, 
catalysis and various medical applications.102-104 
As a combination of electrospraying and spinning process, electrospinning has gained tremendous 
interest. Despite the fact that the theoretical background of the electrospinning process is already 
known since 1745 and first commercial products were used for filter applications in the early 1990, 
electrospinning started to gain rising interest in research after the publication by Reneker et al. in 
1995.104-107 During the electrospinning process, a high electric field is applied to a droplet of a fluid 
coming out from the top of a canula, acting as one of the electrodes. This leads to the ejection of a 
charged jet from the tip of the cone accelerating towards the counter electrode leading to the 
formation of continuous fibers.102 A typical electrospinning setup is shown in Figure 2-8. 
 
Figure 2-8: Typical electrospinning setup.
104 
(Reprinted with permission from Greiner, A; Wendorff J.H. Angewandte Chemie 
International Edition 2007, 46, 5670-5703. Copyright 2007 John Wiley and Sons) 
 
Both the dimensions as well as the quality of the obtained fibers depend not only on the deployed 
polymer, but strongly in the applied physical properties, e.g. voltage, distance between spinneret and 
target or polymer feed rate.108 As the theoretical background of the electrospinning process is behind 
the scope of this chapter, no further discussions of the process itself will be made as detailed 
information can be found elsewhere.102-104 
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Nanofibers obtained via the electrospinning process are widely used for different biomedical 
applications, e.g. tissue engineering, wound dressing or drug release.42, 43, 102 As electrospun fibers 
mimic the dimension of fibrous proteins found in extracellular matrices, they allow infiltration and 
proliferation of cells into the fiber mesh.109, 110 Therefore, the use of fiber meshes as scaffolds for 
tissue engineering applications is of particular interest. Similar to macroscale materials, control of the 
cell response to electrospun nonwovens is limited due to unspecific protein adsorption on the 
nanofibers. To overcome this problem, the formation of nanofibers with increased protein repelling 
properties based on PEG-b-PDLLA has been reported.111 Furthermore, functionalization of the PEG-b-
PDLLA with a bioactive compound, e.g. RGD, prior to the electrospinning process allows the 
formation of nonwovens with controllable cell adhesion within the fiber mesh as shown in Figure 2-
9.111, 112 
 
Figure 2-9: Schematic illustration of cell adhesion on (A) unfunctionalized fibers and (B) fibers functionalized with RGD.
111 
(Reprinted with permission from Grafahrend et al, Biotechnology and Bioengineering 2008, 101, 609-621. Copyright 2008 
John Wiley and Sons) 
 
Most recently, the formation of thiol-reactive PEG-b-PDLLA nanofibers has been reported allowing 
the direct functionalization of the fiber meshes after the electrospinning process.113 
In addition to the use of block copolymers for fibers with decreased protein adsorption and 
controllable cell adhesion, polymer blends have been used as well. Degradable fibers based on 
poly(ε-caprolactone) (PCL) with decreased protein adsorption were produced by electrospinning of a 
polymer blend of PCL and NCO-sP(EO-stat-PO).17 In a comparable approach, PLGA-based fibers were 
achieved using a polymer blend of PLGA and NCO-sP(EO-stat-PO).18, 114, 115 Both fiber meshes based 
on PLC/NCO-sP(EO-stat-PO) and based on PLGA/NCO-sP(EO-stat-PO) could be further functionalized 
to control cell adhesion as shown in Figure 2-10. 
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Figure 2-10: Optical microscope image of human dermal fibroblasts after 24 h in cell culture on electrospun and GRGDS-
functionalized PLGA/sP(EO-stat-PO) fibres.
18 
(Reprinted (adapted) with permission from Grafahrend et al., Nature materials 
2011, 10, 67-73. Copyright 2011 Nature Publishing Group) 
 
In general, electrospinning as a powerful method for the preparation of nanofibers has been widely 
established in research. There are several results shown within this chapter for the straight forward 
functionalization of the applied polymers both prior and after the electrospinning process. None the 
less, especially the chemistry on electrospun polymeric fibers is still challenging and under ongoing 
research.116 
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Chapter 3: Preparation of Vinyl Sulfonate Terminated Linear and Star-shaped 
Polyglycidol2 
 
3.1 Introduction 
Hydrophilic polymers with reactive end groups have found various applications in life science and in 
medicine.1 Over the last decades, poly(ethylene oxide) [PEO, synonym with poly(ethylene glycol) 
(PEG)] has attracted special attention not only due to its hydrophilicity but also due to its good 
protein repelling properties.2-4 PEO was often used for modification of surface properties of 
polymeric materials. To increase the number of reactive end groups the architecture of the polymer 
was changed from linear to star-shaped polymers. PEO brushes and highly branched PEOs have been 
recognized as particularly biocompatible and resistant to protein adsorption due to their hydrophilic, 
uncharged nature.4, 5  
Polyglycidols (PGs) fulfill all structural prerequisites to replace star-shaped PEGs in biomedical 
applications.6 In addition, polyglycidols have the advantage of being highly functional. By copoly-
merization with non-functional monomers, the concentration of functional groups can be adjusted. 
PG with hydroxymethyl side groups and its derivatives are of great interest for applications in 
medicine because of their high functionality, solubility in aqueous media and biocompatibility.6-9  
Several groups have studied the so-called ring-opening multi-branching polymerization of non-
protected glycidol leading to highly branched polymers.7, 10-13 These dendritic structures have gained 
much interest during the last years due to their compact, globular structure in combination with a 
high number of functional groups.9 Especially the use of hyperbranched polyglycidols in the 
formation of nanoparticles and responsive nanocarriers has been recently investigated.14, 15 
Furthermore, hyperbranched polyglycidols can be applied as a monolayer on surfaces where they 
show excellent protein repelling properties comparable to those of poly(ethylene oxide).16 
In general, the microstructure of the hyperbranched polyglycidols is not well controlled. To obtain 
architecturally well defined PG, the hydroxy group of the monomer has to be protected with a 
suitable protecting group leading to highly defined polymers with narrow molecular weight 
                                                          
2
 Selected results within this chapter have been published in the following articles:  
D. Haamann, H. Keul, D. Klee and M. Möller, Functionalization of Linear and Star-shaped Polyglycidols with 
Vinyl Sulfonate Groups and Their reaction with Different Amines and Alcohols, Macromolecules 2010, 43, 6295-
6301. 
D. Haamann, H. Keul, D. Klee and M. Möller, Star Shaped Polyglycidols End Capped with Vinyl Sulfonate Groups 
and Conjugation Reaction with Dodecylamine, Macromolecular Symposia 2010, 296, 1-4. 
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distributions. Mostly ethoxyethyl glycidyl ether (EEGE) was used for the preparation of PG with 
controlled architecture since the protecting group is easily removed from PEEGE under acidic 
conditions. Therefore, anionic polymerization of the protected monomer using different types of 
initiators followed by removal of the protecting group yields polyglycidol with well-defined 
architecture.6, 17-21 
Multifunctional polyglycidols were obtained using a combination of different protecting groups, 
cleavable under different conditions, as shown earlier by Erberich et al.22 Copolymerization of EEGE 
and allylglycidyl ether (AGE) as monomers yields a statistical copolymer in which the acetal 
protecting group can be removed under acidic conditions without affecting the AGE repeating units 
leading to a partially non-protected polyglycidol which can be further functionalized by polymer 
analogous reactions. Another possibility to achieve multifunctional polymers is the use of 
polyglycidol as a core material followed by chemical or enzymatical grafting yielding heterografted 
brush molecules.23 Furthermore, high-molecular mass polyglycidol can be synthesized by a 
monomer-activated anionic polymerization as shown by Gervais et al.24  
Formation and application of synthetic materials in contact with biological matter remain substantial 
challenges of today’s biomedical materials research. Therefore, the formation of biohybrid materials, 
especially of peptide/protein-polymer conjugates, has gained raising interest during the last couple 
of years. Combining peptides/proteins with synthetic polymers in a single hybrid material is of 
interest as it provides unique opportunities to combine the properties of these different classes of 
materials and to overcome some of their limitations.25 
During the last decade the conjugate addition of thiols and/or amines to different unsaturated 
groups has been widely investigated. Polymers equipped with maleimide groups, acrylamide groups, 
and acrylate groups as reactive end groups showed high reactivity towards the addition of thiols.26-29 
Furthermore, the potential of the vinyl sulfone group as reactive end group and their reaction with 
different thiols by a Michael-type addition reaction has been investigated.30-32 However, the 
introduction of vinyl sulfone groups via divinylsulfone is problematic due to the product mixture 
obtained with a homobifunctional reagent. 
Within this chapter, the functionalization of linear and star-shaped polyglycidols with vinyl sulfonate 
end groups is described. These groups are expected to have great potential as a highly reactive linker 
for compounds containing amine and hydroxy groups, but in contrast to the widely used carbonate 
coupler system without the release of small molecules upon addition reaction.6, 22 Furthermore we 
expect a strong selectivity towards amines over alcohols which minimizes side reactions for 
substrates having both functional groups. 
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3.2 Experimental Part 
Materials 
Dimethyl sulfoxide (DMSO), dichloromethane (DCM), tetrahydrofuran (THF) and N,N-
dimethylformamide (DMF) were purchased in analytical grade over molecular sieve from Sigma-
Aldrich and used as received. 
Dipentaerythritol, 1-dodecanol, 1-dodecanthiol, 1-dodecylamine, L-cysteine ethyl ester hydro-
chloride, L-lysine ethyl ester dihydrochloride, β-alanin ethyl ester hydrochloride, glycidol, 
triethylamine and potassium tert.-butoxide (1.0M in THF) were purchased from Sigma-Aldrich and 
used as received. 2-Chloroethylsulfonyl chloride was purchased from Alfa Aesar and used as 
received. Ethoxyethyl glycidyl ether (EEGE) was synthesized according to literature procedure.33 
Linear polyglycidol 3a was synthesized according to Hans et al. using 3-phenyl-1-propanol as 
initiator.18 
All reactions were carried out in nitrogen atmosphere. Nitrogen was passed over molecular sieves (4 
Å). 
 
Synthesis of star-shaped poly(ethoxyethyl glycidyl ether) (3b) 
A solution of dipentaerythritol (2b) (576 mg, 2.72 mmol) and potassium tert.-butoxide (1.0M in THF, 
1.36 mL, 1.3 mmol, 0.1 eq. relative to initiator hydroxy groups) in DMSO was stirred for 10 min at 
room temperature and then the formed tert.-butanol was removed by distillation. EEGE (24.4 mL, 
180 mmol) was added to this solution and was heated to 80 °C for 48 h. The reaction was terminated 
by the addition of a few drops of acetic acid, then dichloromethane was added and the solution was 
washed twice with sat. sodium carbonate solution and dried over magnesium sulfate. The solvent 
was removed in vacuum at 50 °C and a yellow highly viscous liquid was obtained.  
1H NMR (CDCl3, 400 MHz): δ/ppm = 1.19 – 1.30 (m, 6H); 3.46 – 3.64 (m, 7H), 4.71 (s, 1H). 
13C NMR 
(CDCl3, 100 MHz): δ/ppm = 15.2 (30C, CH3); 19.6 (30C; CH3); 45.4 (1C, Cinitiator); 60.6 (30C; CH2); 64.6 
(30C; CH2); 66.0 (3C; CH2endgroup); 69.6 (30C, CH2); 72.5 (3C; CH2endgroup); 78.7 (30C; CH). GPC (THF): 
Mn = 8 450 g mol
-1; Mw=9 200 g mol
-1; PDI =1.08. 
For the synthesis of sPEEGE polymers with different molecular weights, the ratio between 
dipentaerythritol as initator and EEGE as monomer has been varied as follows: 
Mn, calculated = 5 000 g mol
-1: 576 mg dipentaerythritol (2.72 mmol); 12.2 mL EEGE (90 mmol) 
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Mn, calculated = 15 000 gmol
-1: 288 mg dipentaerythritol (1.36 mmol); 18.5 mL EEGE (138 mmol) 
Mn, calculated = 20 000 g mol
-1: 144 mg dipentaerythritol (0.68 mmol); 12.9 mL EEGE (94 mmol) 
 
Synthesis of vinyl sulfonate terminated star-shaped poly(ethoxyethyl glycidyl ether) (4a,b) 
Star-shaped poly(ethoxyethyl glycidyl ether) (3b) (sPEEGE) (10 g, 1 mmol, 6 mmol in relation to end 
group) and triethylamine (3.2 mL, 24 mmol) were dissolved in DCM (20 mL) and cooled to 0 °C. 
Afterwards 2-chloroethylsulfonyl chloride (1.2 mL, 12 mmol, 2 eq.) was added and the solution 
warmed up to r.t. while stirring for 60 min. For the investigation of dimer formation, the amount of 
2-chloroethylsulfonyl chloride was reduced to 1 eq. or 1.5 eq (0.6 mL, 6 mmol or 0.9 mL, 9 mmol) 
respectively. The reaction was terminated by addition of sat. sodium carbonate solution. The organic 
phase was washed twice with sat. sodium carbonate solution and twice with water and then dried 
over magnesium sulfate. After removal of the solvent a highly viscous brownish liquid was obtained.  
Yield: 95% 
Degree of functionalization: 100 %.  
1H-NMR (CDCl3, 400 MHz): δ/ppm = 1.18 – 1.28 (m, 6H), 3.46 – 3.83 (m, 7H), 4.68 (s, 1H), 6.05 (d, 
0.08H), 6.39 (d, 0.08H), 6.73 (d, 0.08H). 13C-NMR (CDCl3, 100 MHz): δ/ppm = 15.3 (CH3), 19.8 (CH3), 
60.8 (CH2), 65.1 (CH2), 70.1 (CH2), 78.9 (CH2), 99.8 (CH), 128.6 (CH), 133.9 (CH2). IR: υ/cm-1 = 1366 (s, 
R-SO2-O); 927 (s, C=C), 797 (s,C=C). GPC (THF): Mn = 9 200 g mol
-1, Mw = 9 800 g mol
-1, PDI = 1.07. 
Linear poly(ethoxyethyl glycidyl ether) (3a) was treated in similar manner to achieve 4a.  
1H NMR (DMSO-d6, 400 MHz): δ/ppm = 1.09 – 1.18 (m, 6H); 1.78 (q, 0.25H); 2.61 (t, 0.25H); 3.33-3.75 
(m, 7H); 4.63 (s, 1H); 6.21-6.31 (m, 0.25H); 6.94 (m, 0.13H); 7.19-7.28 (m, 0.75H). 13C NMR (DMSO-d6, 
100 MHz): δ/ppm = 15.1 (CH3); 19.6 (CH3); 30.9 (CH2); 31.6 (CH2); 60.1 (CH2); 64.6 (CH2); 68.2 (CH2); 
69.6 (CH2); 78.2 (CH2); 99.1 (CH); 125.6 (CHarom); 128.1 (CHarom); 129.7 (CH); 133.6 (CH); 141.6 (Carom). 
GPC (THF): Mn = 1 400 g mol
-1; Mw = 1 530 g mol
-1; PDI =1.09.  
Synthesis of vinyl sulfonate terminated star-shaped polyglycidol (5) 
Vinyl sulfonate terminated, six-arm PEEGE (4b) (10g, 1 mmol) was dissolved in 50 mL THF and then 5 
mL conc. hydrochloric acid was added. The solution was stirred for one hour and then diluted with 10 
mL dest. H2O and 10 mL dichloromethane. After separation the aqueous phase was washed three 
times with 10 mL dichloromethane each and then the solvent was removed under vacuum resulting 
in the product as a highly viscous solution. 
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Yield: 100% 
1H-NMR (CDCl3, 400 MHz): δ/ppm = 3.38 – 3.77 (m, 5H), 4.82 (s, OH), 6.27 (m, 0.16H), 7.00 (m, 
0.08H). 13C-NMR (CDCl3, 100 MHz): δ/ppm = 60.7 (CH2), 69.2 (CH2), 79.9 (CH), 129.6 (CH), 133.6 (CH2). 
GPC (DMF): Mn = 4 500 g mol
-1, Mw = 4 700 g mol
-1, PDI = 1.05 
Measurements 
1H NMR and 13C NMR spectra were recorded on a Bruker DPX-400 FTNMR spectrometer at 400 MHz 
and 100 MHz respectivelly. Deuterated chloroform (CDCl3) or deuterated dimethyl sulfoxide (DMSO-
d6) were used as solvents, and tetramethylsilane (TMS) served as internal standard.  
Size exclusion chromatography (SEC) analyses were carried out at 35 °C using a high-pressure liquid 
chromatography pump (ERC HPLC 64200) and a refractive index detector (ERC-7215a). The eluting 
solvent was tetrahydrofuran (HPLC grade) with 250 mg L-1 2,6-di-tert-butyl-4-methylphenon and a 
flow rate of 1 mL min-1. Five columns with MZ gel were applied. The length of the first column was 50 
mm, and 300 mm for the other four columns. The diameter of each column was 8 mm, the diameter 
of the gel particles 5 µm, and the nominal pore widths were 5 Å, 50 Å, 100 Å, 1000 Å, and 10 000 Å, 
respectively. Calibration was achieved using poly(methyl methacrylate) standards. 
 
3.3 Results and Discussion 
The goal of this work was the preparation of linear and star-shaped polyglycidols end group 
functionalized with vinyl sulfonate groups. The advantage of using this group as a linker is based on 
the selective introduction of the group as well as the high selectivity of the vinyl sulfonate groups 
towards the addition of amines, alcohols or other nucleophiles. The synthetic strategy for the 
preparation of functionalized linear and star shaped polyglycidols comprises (i) the synthesis of the 
protected polyglycidol, (ii) the introduction of the reactive vinyl sulfonate end group and (iii) the 
cleavage of the protecting group. Vinyl sulfonate group has great potential in ligation chemistry due 
to their high reactivity towards different molecules with amine moieties (Figure 3-1).  
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Figure 3-1: Synthesis and functionalization of polyglycidols with vinyl sulfonate groups 
The first step in our strategy is the synthesis of linear and six arm star-shaped polyglycidols. Due to 
previously discussed reasons, the acetal protecting group was chosen; the monomer ethoxyethyl 
glycidyl ether (EEGE) was prepared from glycidol and ethyl vinyl ether.33 The same protected 
monomer was used to synthesize linear and star-shaped polymers as shown in Figure 3-2.  
 
Figure 3-2: Synthesis route of functionalized linear and star shaped PG 5a, 5b. 
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The synthesis of linear polyglycidol was performed via anionic ring opening polymerization of 
protected glycidol (1) using 3-phenylpropanol (2a) as initiator as previously described by Hans et al.18 
Star-shaped polyglycidol was synthesized using dipentaerythritol (2b) as initiator. For activation of 
the hydroxy groups of the initiator 0.1 eq potassium tert.-butoxide was used. For a controlled 
polymerization it is important that only ca. 10% of the hydroxy groups of the initiator are activated 
while the remaining 90% are latent. After complete removal of formed tert.-butanol the monomer 
was added and the polymerization started by heating the solution in dimethyl sulfoxide up to 90 °C. 
After 48 h the PEEGEs 3a,b were obtained in almost quantitative yield.  
Quantitative 13C NMR analysis of the star-shaped PEEGE 3b proved the six end groups per molecule 
and therefore the successful formation of a six arm star polymer (Figure 3-3). GPC analysis shows 
that for both initiators relatively narrowly distributed polymers are obtained.  
 
Figure 3-3: Detail of quantitative 
13
C NMR spectrum of 3b. Signals 2e and 3e indicate carbon atoms of the end-groups of the 
polymer. 
Polymers with different molecular weights could be obtained by variation of the ratio between 
dipentaerythritol as initiator and EEGE. The relation between the theoretical molecular weight 
calculated from the monomer feed and the resulting molecular weight of the synthesized polymers is 
shown in Figure 3-4. 
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Figure 3-4: Relation between the calculated and the actually achieved molecular weight of sPEEGE derived from different 
monomer:initiator ratios. 
All polymers exhibited molecular weights in the desired range. In most cases, slightly higher 
molecular weights than calculated were obtained. For further reactions, poly(ethoxyethyl glycidyl 
ether) with a molecular weight of approx. 10 000 g mol-1 has been used. 
In the second step the previously synthesized polymers were end group functionalized with the vinyl 
sulfonate group. For the introduction of reactive end groups both the linear and the star shaped 
polyglycidol 3a, 3b were treated with triethylamine and 2-chloroethylsulfonyl chloride in dichloro-
methane at room temperature (Figure 3-2).  
The successful addition of one or six vinyl sulfonylester groups to the polymer chain was proved by 
NMR spectroscopy as shown in Figure 3-5. 
Chapter 3: Preparation of Vinyl Sulfonate Terminated Linear and Star-shaped Polyglycidol 
 
34 
 
Figure 3-5: 
1
H NMR spectrum of functionalized linear PEEGE 4a. Comparison of initiator signals 1, 2 and 3 and signals from 
unsaturated protons 14, 15 and 16. 
The successful functionalization was confirmed by the signals of the hydrogen atoms related to the 
unsaturated double bond of the end group (14, 15 and 16 in Figure 3-4). For all synthesized polymers, 
high functionalization degrees were observed. 
To investigate the potential formation of dimers during functionalization procedure, sPEEGE was 
treated with various amounts of 2-chloroethylsulfonyl chloride and the resulting polymers were 
analyzed by SEC to detect dimers. Furthermore, NMR spectroscopy was used for the determination 
of the degree of functionalization (Table 3-1, Figure 3-6). 
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Table 3-1: Influence of the amount of 2-chloroethylsulfonyl chloride on the formation of dimers during the functionalization 
process 
Compound Amount of 2-
chloroethyl-
sulfonyl chloride 
Mw, SEC 
[g mol-1] 
Mn, SEC 
[g mol-1l] 
PDI Degree 
of 
funct.a 
sPEEGE - 9 600 9 000 1.06 n.a. 
VS-sPEEGE  
VS-sPEEGE 
VS-sPEEGE[b] 
1 eq 
1.5 eq 
2 eq 
12 900 
9 800 
10 100 
11 500 
9 200 
9 800 
1.12 
1.07 
1.03 
60% 
100 % 
100 % 
[a] determined by 1H NMR analysis, [b] derived from polymer with slightly different molecular mass 
(Mw = 9 600 g mol
-1 Mn = 9 300 g mol
-1, PDI = 1.03); n.a. = not applicable 
 
Figure 3-6: SEC traces of sPEEGE prior and after treatment with different amounts of 2-chloroethylsulfonyl chloride 
Treatment of the polymer with one eq. of 2-chloroethylsulfonyl chloride lead to minor dimerization 
as determined by SEC analysis but using 1.5 or 2 eq. of the reagent led to no crosslinking and a 100% 
degree of functionalization (Table 3-1, Figure 3-4). Therefore, functionalization was carried out with 
an excess of 2-chloroethylsulfonyl chloride to avoid dimerization reactions and to achieve high 
functionalities. 
In the third and last step, the acetal protecting group was removed by treatment with diluted 
hydrochloric acid. This treatment does not affect the vinyl sulfonate functionality and led to end 
group functionalized, star-shaped polyglycidol (5a, 5b) as confirmed by NMR spectroscopy (Figure 3-
7).  
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Figure 3-7: 
1
H-NMR spectra of VS-sPG. 
 
3.4 Conclusion 
Linear and star-shaped poly(ethoxyethyl glycidyl ether)s were successfully synthesized by anionic 
ring-opening polymerization of acetal protected glycidol monomer followed by successful 
introduction of the vinyl sulfonate group. Depending on the applied amount of 2-chloroethylsulfonyl 
chloride, dimer formation can be completely suppressed by using an excess of the dichloride. Finally, 
the acetal protecting group can be easily removed without affecting the vinyl sulfonate functionality 
leading to vinyl sulfonate terminated, star-shaped polyglycidols.  
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Chapter 4: Reactivity of Vinyl Sulfonate Terminated Polyglycidols in Organic 
and Aqueous Solutions3 
 
4.1 Introduction 
During the last decades, the synthesis of polymer conjugates has gained growing interest. Hybrid 
materials with unique properties are obtained when peptides or proteins are combined with 
polymers.1, 2 Today, the conjugation of proteins with poly(ethylene glycol) (PEG), so called 
PEGylation, has been established as a widely used method for improving the in-vivo properties of 
therapeutic drugs.3-6 Many strategies for the preparation of such conjugates have been developed 
and summarized in excellent reviews.1, 2, 7 Three synthetic strategies towards protein/peptide-
polymer conjugates have been reported: (i) polymerization of suitable monomers starting with 
protein/peptide macroinitiators, (ii) synthesis of peptides on synthetic polymers and (iii) coupling of 
reactive polymers to peptides or proteins.2 
For the latter case, the coupling reaction has to fulfill specific requirements; it has to be 
chemoselective and the conversion must occur under mild conditions in water, especially when 
active biological molecules are used as organic solvents and elevated temperatures are detrimental 
for the activity of the biological molecule. 
Reactions fulfilling these requirements can be considered as click-type reactions according to the 
definition given by Sharpless et al.8 Reactions applied to prepare conjugates include Heck, 
Sonogashira and Suzuki coupling, Diels-Alder- and Huisgen cycloaddition as well as Staudinger 
ligation and many others. Nonetheless, a major drawback for many of these reactions is the need of 
metal catalysts (e.g. Heck coupling, Staudinger ligation, and copper-catalyzed Huisgen cycloaddition) 
which are often difficult to remove, especially when functional hydrogels are prepared and the 
catalyst is enclosed within the three-dimensional structure. Metal-free click reactions often need 
elevated temperatures (e.g. Huisgen cycloaddition) or specially designed substructures like 
cyclooctine which is difficult to introduce into the substrate or biological molecule.9, 10 Most recently, 
the synthesis of hydrogels based on modified poly(methacrylic acid) in aqueous solution has been 
reported using both allyl- and thiol-functionalized poly(methacrylic acid) in a thiol-ene click 
                                                          
3
 Selected results within this chapter have been published in the following articles:  
D. Haamann, H. Keul, D. Klee and M. Möller, Functionalization of Linear and Star-shaped Polyglycidols with 
Vinyl Sulfonate Groups and Their reaction with Different Amines and Alcohols, Macromolecules 2010, 43, 6295-
6301. 
D. Haamann, H. Keul, D. Klee and M. Möller, Star Shaped Polyglycidols End Capped with Vinyl Sulfonate Groups 
and Conjugation Reaction with Dodecylamine, Macromolecular Symposia 2010, 296, 1-4. 
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reaction.11 Furthermore, the synthesis of a poly(N-isopropyl acrylamide) based hydrogel in aqueous 
solution by a Diels-Alder reaction had been published recently using poly(N-isopropylacrylamides-co-
furfuryl methacrylate) as diene and a water soluble bismaleimide as cross-linker.12 In both cases, the 
crosslinking reaction took place in aqueous solution without the need of any catalyst, but especially 
the latter reaction needed longer reaction times (up to 76 h) for full conversion, which can be a 
major drawback for biomaterial applications. Other reactions of substrates with highly reactive end 
groups, e.g. isocyanate end groups, cannot be performed in aqueous medium due to side reactions 
with water. 
One reaction which perfectly fulfills all discussed requirements is the Michael-type addition reaction. 
Hubbell et al. described the use of PEG-vinyl sulfones in aqueous solutions for conjugation reactions 
as well as for the synthesis of hydrogel networks containing different types of recombinant 
proteins.13-16 However, the synthesis of vinyl sulfone terminated polymers is challenging due to the 
use of divinyl sulfone as a reagent, which beside the wanted product leads to the formation of 
dimers due to the fact that divinylsulfone is a homobifunctional reagent.  
In organic synthesis, vinyl sulfonates are used as Michael-acceptors instead of vinyl sulfones which 
can react with amines in a vinylogous reaction to form stable conjuates.17, 18 The vinyl sulfonate 
group can be introduced using vinyl sulfonyl chloride as starting material.17, 19, 20 As an alternative,  
2-chloroethylsulfonyl chloride can be used generating vinyl sulfonyl chloride in situ by treatment with 
triethylamine.21-23 
In chapter 3 the synthesis of linear and star-shaped polyglycidols (PGs) with vinyl sulfonate end 
groups has been described. PGs as well as their esters are known to be highly biocompatible showing 
no influence on the metabolism in both animal and human bodies.24-28 Furthermore, it was shown 
that polyglycidols are assimilated and eliminated rapidly from the body without being 
catabolised.28, 29 Additionally, polyglycidols are FDA approved for the use as food and drug additive.30 
In this chapter the use of vinyl sulfonate terminated, star-shaped polyglycidol (VS-sPG) and 
poly(ethoxyethyl glycidyl ether) (VS-sPEEGE) for conjugation reactions with amines for the synthesis 
of polymer-peptide/protein conjugates in both aqueous and organic solutions is reported.  
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4.2 Experimental Part 
Materials 
Dimethyl sulfoxide (DMSO), dichloromethane (DCM), tetrahydrofuran (THF) and N,N-dimethyl-
formamide (DMF) were purchased in analytical grade over molecular sieve from Sigma-Aldrich and 
used as received. 
1-Dodecanol, 1-dodecanthiol, 1-dodecylamine, L-cysteine ethyl ester hydrochloride, L-lysine ethyl 
ester dihydrochloride, β-alanine ethyl ester hydrochloride, triethylamine and p-toluenesulfonyl 
chloride were purchased from Sigma-Aldrich and were used as received.  
For reactions in organic solution, vinyl sulfonate terminated star-shaped poly(ethoxyethyl glycidyl 
ether) (VS-sPEEGE) (Mw =  17 400 g mol
-1, Mn = 16 700 g mol
-1, PDI = 1.04) has been prepared and 
characterized according to the synthesis described in chapter 3. For reactions in aqueous solution, 
vinyl sulfonate terminated star-shaped polyglycidol (VS-sPG) (Mw = 4 700 g mol
-1, Mn = 4 500 g mol
-1, 
PDI = 1.05) has been prepared and characterized as described in detail in chapter 3.  
Synthesis of tosylate terminated sPEEGE 
A solution of 5 g star-shaped poly(ethoxyethyl glycidyl ether) (2 mmol in relation to end group) in 
15 mL THF and 0.55 mL Et3N (4 mmol, 2 eq) was stirred at 0 °C for 10 mi. p-Toluenesulfonyl chloride 
(0.6 g, 3 mmol, 1.5 eq) was added and the solution was stirred for another hour at 0 °C. Afterwards, 
the solution was warmed up to r.t. and then was stirred over night. The reaction was terminated by 
the addition of 15 mL sat. sodium bicarbonate solution and then dichloromethane was added. The 
organic phase was washed once with 15 mL sat. sodium bicarbonate solution, twice with 10 mL H2O 
each and then dried over magnesium sulfate. The solvent was removed in vacuum and the product 
was obtained as yellow, viscous liquid. 
1H NMR (CDCl3, 400 MHz): δ/ppm = 1.19 – 1.30 (m, 6H); 2.50 (s, 0.12H); 3.46 – 3.64 (m, 7H), 4.70 (s, 
1H), 7.43 (d, 0.08 H), 7.94 (d, 0.08 H). 
Conjugation reaction of VS-sPEEGE with dodecylamine in THF 
In a typical addition reaction, dodecylamine (1.44 mmol) was dissolved in THF (5 mL) and the solution 
was stirred for 10 min. Afterwards vinyl sulfonate terminated star-shaped poly(ethoxyethyl glycidyl 
ether) (1 g, 0.06 mmol) dissolved in THF (5 mL) was added and the mixture was stirred at r.t. for 60 
min. The reaction was terminated by the addition of water, diluted with DCM, the organic phase was 
washed twice with water and then dried over magnesium sulfate. The solvent was removed in 
vacuum resulting in a highly viscous liquid.  
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1H NMR (CDCl3, 400 MHz): δ/ppm = 0.88 (t, 0.3H); 1.18 – 1.43 (m, 8H); 2.59 (t, 0.2H); 3.1 (t, 0.2H); 
3.20 – 3.75 (m, 7,5H); 4.7 (t, 1H). 13C NMR (CDCl3, 100 MHz): δ/ppm = 14.0 (CH3); 15.3 (CH3); 19.7 
(CH3); 22.6 (CH2); 27.3 (CH2); 29.6 (CH2); 31.9 (CH2); 43.7 (CH2); 49.5 (CH2); 51.0 (CH2); 60.7 (CH2); 65.2 
(CH2); 69.9 (CH2); 78.9 (CH2); 99.8 (CH). 
Conjugation reaction of VS-sPEEGE with dodecanol in THF 
In a typical addition reaction dodecanol (1.44 mmol) was dissolved in THF (5 mL), tBuLi (1.44 mmol, 
4 eq.) was added and the solution was stirred for 10 min. Afterwards vinyl sulfonate terminated star-
shaped poly(ethoxyethyl glycidyl ether) (1 g, 0.06 mmol) dissolved in THF (5 mL) was added and the 
mixture was stirred at r.t. for 60 min. The reaction was terminated by the addition of water, diluted 
with DCM, the organic phase was washed twice with water and then dried over magnesium sulfate. 
The solvent was removed in vacuum resulting in a highly viscous liquid.  
1H NMR (CDCl3, 400 MHz): δ/ppm = 0.90 (t, 0.3H); 1.18 – 1.43 (m, 8H); 2.59 (t, 0.2H); 3.1 (t, 0.2H); 
3.23 – 3.75 (m, 7,5H); 4.7 (t, 1H). 13C NMR (CDCl3, 100 MHz): δ/ppm = 14.0 (CH3); 15.3 (CH3); 19.7 
(CH3); 22.6 (CH2); 27.3 (CH2); 29.6 (CH2); 31.9 (CH2); 43.7 (CH2); 49.5 (CH2); 51.0 (CH2); 60.7 (CH2); 65.2 
(CH2); 69.9 (CH2); 78.9 (CH2); 99.8 (CH). 
Conjugation reaction of tosylate terminated sPEEGE with dodecylamine in THF 
Similar to other conjugation reactions, dodecylamine (1.44 mmol) was dissolved in THF (5 mL) and 
the solution was stirred for 10 min. Afterwards tosylate terminated star-shaped poly(ethoxyethyl 
glycidyl ether) (1 g, 0.06 mmol) dissolved in THF (5 mL) was added and the mixture was stirred at r.t. 
for 60 min. The reaction was terminated by the addition of water, diluted with DCM, the organic 
phase was washed twice with water and then dried over magnesium sulfate. The solvent was 
removed in vacuum resulting in a highly viscous liquid.  
1H NMR (CDCl3, 400 MHz): δ/ppm = 1.19 – 1.30 (m, 6H); 2.50 (s, 0.12H); 3.46 – 3.64 (m, 7H), 4.70 (s, 
1H), 7.40 (d, 0.08 H), 7.85 (d, 0.08 H). 
Synthesis of polyglycidols endcapped with dodecylamine ethyl sulfonate groups 
The dodecylamine ethyl sulfonate endcapped sPEEGE (1 g, 0.06 mmol) was dissolved in THF (10 mL) 
and conc. hydrochloric acid (1 mL) was added. The mixture was stirred for 120 min and then diluted 
with DCM. The aqueous phase was separated and the solvent was removed in vacuum resulting in a 
brownish highly viscous liquid.  
1H NMR (DMSO-d6, 400 MHz): δ/ppm = 0.86 (t, 0.3H); 1.04 – 1.25 (m, 2H); 3.43 – 3.54 (m, 5H); 4.09 
(bs, OH). 
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Conjugation reaction of VS-sPEEGE and linear vinyl sulfonate terminated PEEGE with β-alanine 
ethyl ester in DMF 
β-Alanine ethyl ester hydrochloride (0.288 g, 1.875 mmol) was dissolved in DMF (5 mL) and tri-
ethylamine (0.35 mL, 2.25 mmol, 1.2 eq) was added. The mixture was stirred for 10 min at room 
temperature and then star-shaped polyglycidol (1 g, 0.4 mmol in respect to end groups) or its linear 
analogue (0.5 g, 0.4 mmol) dissolved in DMF (5 mL) was added. The mixture was stirred for 60 min 
and then the reaction was terminated by addition of water. DCM was added and the organic phase 
was washed twice with water and then dried over magnesium sulfate. The solvent was removed in 
vacuum resulting in a highly viscous liquid.  
Linear PEEGE-alanine conjugate:  
1H NMR (DMSO-d6, 400 MHz): δ/ppm = 1.09 – 1.17 (m, 6.5H); 1.78 (q, 0.3H); 2.39 (t, 0.3H); 2.63 (t, 
0.3H); 3.37 – 3.75 (m; 8H); 4.03 (t, 0.3H); 4.63 (bs, 1H); 7.17 – 7.26 (m, 0.7H). 13C NMR (DMSO-d6,  
100 MHz): δ/ppm = 14.0 (CH3); 15.1 (CH3); 19.6 (CH3); 30.7 (CH2); 30.9 (CH2); 34.4 (CH2); 43.0 (CH2); 
44.2 (CH2); 50.2 (CH2); 60.1 (2x CH2); 64.6 (CH2); 69.3 (2x CH2); 78.2 (CH); 99.1 (CH); 125.6 (CHarom); 
128.1 (4x CHarom); 144.6 (Carom); 171.8 (C=O). 
Star shaped PEEGE-alanine conjugate:  
1H NMR (CDCl3, 400 MHz): δ/ppm = 1.16 – 1.26 (m, 6.3H); 2.46 (q, 0.2H); 3.41 – 3.66 (m, 7.6H); 4.12 
(q, 0.2H); 4.7 (s, 1H). 13C NMR (CDCl3, 100 MHz): δ/ppm = 14.3 (CH3); 15.4 (CH3); 19.8 (CH3); 34.8 
(CH2); 37.6 (CH2); 43.7 (CH2); 44.7 (CH2); 60.8 (2x CH2); 64.8 (CH2); 70.1 (CH2); 78.9 (CH); 99.7 (CH); 
127.4 (C=O). 
Conjugation reaction of VS-sPEEGE and linear vinyl sulfonate terminated PEEGE with cysteine ethyl 
ester in DMF 
Cysteine ethyl ester hydrochloride (0.348 g, 1.875 mmol) was dissolved in DMF (5 mL) and 
triethylamine (0.31 mL, 2.25 mmol, 1.2 eq) was added. The mixture was stirred for 10 min at room 
temperature and then star-shaped polyglycidol (1 g, 0.4 mmol in respect to end groups) or its linear 
analogue (0.5 g, 0.4 mmol) dissolved in DMF (5 mL) was added. The mixture was stirred for 60 min 
and then the reaction was terminated by the addition of water. After addition of DCM, the organic 
phase was washed twice with water and was dried over magnesium sulfate. The solvent was 
removed in vacuum resulting in a highly viscous liquid.  
Linear PEEGE-cysteine conjugate:  
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1H NMR (DMSO-d6, 400 MHz): δ/ppm = 1.09 – 1.17 (m, 6.5H); 1.78 (q, 0.3H); 2.61 (t, 0.3H); 2.96 (t, 
0.3H); 3.38 – 3.70 (m, 8.2H); 4.11 (m, 0.3H); 4.65 (bs, 1H); 7.14 – 7.28 (m, 0.7H). 13C NMR (DMSO-d6, 
100 MHz): δ/ppm = 14.0 (CH3); 15.1 (CH3); 19.7 (CH3); 25.2 (CH3); 30.1 (CH2); 31.0 (CH2); 31.6 (CH2); 
43.5 (CH2); 60.3 (2x CH2); 64.3 (CH2); 69.4 (CH2); 69.7 (CH2 + CH); 78.3 (CH); 99.1 (CH); 125.6 (CHarom); 
128.2 (4x CHarom); 141.6 (Carom); 173.7 (C=O).  
Star shaped PEEGE-cysteine conjugate:  
1H NMR (CDCl3, 400 MHz): δ/ppm = 1.17 – 1.28 (m, 6.3H); 1.92 (bs, SH); 2.91 (m, 0.2H); 3.40 – 3.80 
(m, 7.7H); 4.21 (m, 0.3H); 4.69 (s, 1H). 13C NMR (CDCl3, 100 MHz): δ/ppm = 14.2 (CH3); 15.4 (CH3); 
19.8 (CH3); 25.9 (CH2); 43.6 (CH2); 53.6 (CH2); 60.8 (CH2); 61.5 (CH2); 64.8 (CH2); 70.1 (CH2 + CH); 78.9 
(CH); 99.7 (CH); 173.7 (C=O).  
Conjugation reaction of VS-sPG with β-alanine ethyl ester hydrochloride in H2O 
In a typical conjugation reaction 150 mg β-alanine ethyl ester hydrochloride (1 mmol, 4 eq) was 
dissolved in 5 mL H2O and then 0.14 mL triethylamine (1 mmol, 4 eq) was added. Afterwards 200 mg 
VS-sPG (0.24 mmol in relation to end groups), dissolved in 5 mL H2O, was added and the solution was 
stirred for 60 min at room temperature. Subsequently the solution was diluted with 10 mL DCM and 
the aqueous phase was washed three times with DCM. After evaporation of the solvent the residue 
was dissolved in H2O again and then purified by dialysis against H2O.  
1H-NMR (CDCl3, 400 MHz): δ/ppm = 1.25 (t, 3H), 2.33 (NH), 3.01 – 3.61 (m), 4.63 (OH). 
Measurements 
1H NMR and 13C NMR spectra were recorded on a Bruker DPX-400 FTNMR spectrometer at 400 MHz 
and 100 MHz respectively. Deuterated chloroform (CDCl3) or deuterated dimethyl sulfoxide  
(DMSO-d6) were used as solvents, and tetramethylsilane (TMS) served as internal standard.  
Size exclusion chromatography (SEC) analyses were carried out at 35 °C using a high-pressure liquid 
chromatography pump (ERC HPLC 64200) and a refractive index detector (ERC-7215a). The eluting 
solvent was tetrahydrofuran (HPLC grade) with 250 mg L-1 2,6-di-tert-butyl-4-methylphenon and a 
flow rate of 1 mL min-1. Five columns with MZ gel were applied. The length of the first column was 
50 mm, and 300 mm for the other four columns. The diameter of each column was 8 mm, the 
diameter of the gel particles 5 µm, and the nominal pore widths were 5 Å, 50 Å, 100 Å, 1000 Å, and 
10 000 Å, respectively. Calibration was achieved using poly(methyl methacrylate) standards. 
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4.3 Results and Discussion 
In chapter 3, the preparation of linear as well as star-shaped vinyl sulfonate terminated polyglycidol 
and poly(ethoxyethyl glycidyl ether) has been described. In this chapter, the unique reactivity of the 
functionalized polymers towards amines is under investigation. In general, two different pathways 
for the conjugate addition of an amine to a vinyl sulfonate terminated polyglycidol are possible as 
shown in Figure 4-1. 
 
Figure 4-1: Potential reaction pathways for the formation of a polyglycidol-amine conjugate. 
Starting from vinyl sulfonate terminated, star shaped PEEGE (1), the polyglycidol-amine conjugate (4) 
can be synthesized either by (i) an addition reaction in an organic solvent to form the sPEEGE-amine 
conjugate (2) followed by cleavage of the acetal group or (ii) by cleavage of the acetal protecting 
group to form VS-sPG (3) followed by the addition reaction in an aqueous solution. Especially the 
latter reaction pathway is expected to be very promising for conjugation reactions with biomolecules 
as they are normally stable only in aqueous solution. None the less, both reaction pathways were 
studied in the following.  
 
Chapter 4: Reactivity of Vinyl Sulfonate Terminated Polyglycidols  
 
46 
In the first part of this chapter, the reactivity of the functionalized polymers towards the addition of 
amines in organic solution has been investigated. Therefore, model reactions were carried out with 
dodecylamine as an aliphatic primary amine in the absence of a catalyst at room temperature to 
form the desired conjugate. The structure of the product could be verified by 1H NMR analysis 
showing the disappearance of the protons attached to sp2-hybridized carbon atoms.  
In a second step, the conjugate was treated with aqueous hydrochloric acid to cleave the acetal 
protection group. Removal of the protection group was successful without affecting the sulfonate 
alkyl bond; as a consequence polyglycidol with dodecylamine ethyl sulfonate end groups was 
obtained. The complete removal of the protecting group was proven by 1H NMR analysis (Figure 4-2). 
 
Figure 4-2: 
1
H NMR spectrum of the polyglycidol-dodecylamine conjugate. 
Furthermore, the obtained conjugates show good solubility in less-polar solvents like chloroform; the 
non-functionalized polyglycidol is insoluble in chloroform and is soluble only in highly polar solvents 
like water or DMF. This change in solubility proves the successful addition of the long alkyl chain on 
the highly hydrophilic polymer.  
Additionally the reactivity of the functionalized polymers towards alcohols had been investigated by 
the reaction with dodecanol. In this case the addition of a strong base like tBuLi was necessary for the 
formation of the alcoholate prior to the addition reaction. The expected structure of the product was 
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confirmed by 1H NMR analysis. The spectrum is not shown here because it showed no significant 
difference compared to the polyglycidol-dodecylamine conjugate (Figure 4-2) as the neighboring 
carbon atoms of the oxygen or nitrogen atom, respectively, are appearing within the area of the 
signals of the polymer backbone. 
The successful conjugation between both amines or alcohols and the functionalized polymer can be 
easily proven by NMR spectroscopy. None the less, two different conjugation reaction pathways are 
supposable for the conjugation of a nucleophile to the vinyl sulfonate groups: (i) the addition of the 
nucleophile to the vinyl group or (ii) an elimination reaction as sulfonate groups are known to 
activate the carbon-oxygen bond and therefore allow the attack of the nucleophile at the 
neighboring carbon atom. Unfortunately, the saturated proton signals derived from the vinyl group 
(signals 4 and 5 in Figure 4-2) cannot be detected due to overlapping of these signals with the 
polymer backbone. For the determination of the reaction mechanism, polyglycidol has been 
equipped with the ester of the p-toluenesulfonic acid (tosylate) which is often used for the activation 
of hydroxy groups for elimination reaction. In difference to the vinyl sulfonate group, the tosylate 
group can only activate the hydroxy group of the polymer for elimination reaction and no addition 
reaction can take place. Therefore, tosylate end group functionalized sPEEGE has been treated with 
dodecylamine under conditions suitable for the conjugation of dodecylamine to VS-sPEEGE shown 
previously in this chapter. The resulting conjugates were analyzed by NMR spectroscopy as shown in 
Figure 4-3. 
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Figure 4-3: NMR spectra of tosylate functionalized sPEEGE prior (upper) and after (lower) reaction with dodecylamine 
towards the formation of polymer-amine conjugates. 
The conjugation of dodecylamine to a tosylate functionalized sPEEGE could not be achieved under 
conditions suitable for conjugation to vinyl sulfonate terminated polymers. This indicates clearly that 
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the conjugation of the amine to the polymer occurred via an addition reaction of the nucleophile at 
the vinyl bond rather than elimination of the activated hydroxy group by the amine. 
To investigate the potential to form conjugates between the polymer and biomolecules, e.g. 
peptides, the reactivity of the end capped polymers towards different amino acids was investigated. 
β-Alanine ethyl ester hydrochloride and cysteine ethyl ester hydrochloride were chosen as reaction 
partners due to the different number and type of functional groups in the molecules. The alanine 
derivate is carrying only one amino group and therefore only one reaction side is available, but the 
cysteine ester has two functional groups and therefore two possible sides for the conjugate addition. 
The reactions were carried out in the same manner as described for the model reaction with 
dodecylamine but with addition of 1.1 eq of triethylamine as scavenger for the hydrochloric acid and 
for maintenance of a non acidic medium (Figure 4-4). 
 
Figure 4-4: Reaction scheme for the addition of β-alanine ethyl ester hydrochloride to linear or star shaped PEEGE. For 
better visibility only one arm of the star polymer is shown here. 
The addition of β-alanine to the end functionalized polymers 1 let to the expected adduct in a very 
straightforward manner within a few minutes reaction time and formation of the desired 
polyglycidol-alanine ester conjugate. The structure could be verified by NMR analysis. The addition of 
cysteine did also proceed yielding the polyglycidol-cysteine ester conjugate. As no crosslinking could 
be observed during this reaction, it is a clear hint that the reaction does only take place at one of the 
two functional groups. The structure of the conjugate could be verified by NMR spectroscopy as 
shown in Figure 4-5. 
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Figure 4-5: 
1
H NMR spectrum of the polyglycidol-cysteine conjugate. 
As the 1H NMR spectrum does not show any free amine groups but free thiol groups, the reaction 
likely took place at the amino side and not at the thiol side. This is remarkable due to the fact that 
the classical Michael addition under alkaline conditions is significantly more reactive towards thiols 
than amines and further investigations have to be made to find an explanation for this effect.31 
Despite the fact that the conjugation addition reactions could be carried out in a straightforward 
manner in organic solutions, reactions in aqueous solution are expected to be very promising for the 
preparation of polymer-peptide conjugates as most biomolecules are only stable at near-
physiological conditions. Therefore, in the second part of this chapter, the reactivity of vinyl 
sulfonate terminated polyglycidol in aqueous solution is under investigation. 
The potential of the vinyl sulfonate group for conjugation reactions with amines in aqueous solution 
was shown by a model reaction with β-alanine ethyl ester hydrochloride forming the polyglycidol-
alanine conjugate within minutes at room temperature in aqueous solution as shown in Figure 4-6.  
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Figure 4-6: Conjugation reaction of vinyl sulfonate terminated, star-shaped polyglycidol with β-alanine ethyl ester 
hydrochloride in aqueous solution. 
The successful addition of the amino acid to the polymer was proven by NMR analysis (Figure 4-7). 
 
Figure 4-7: 
1
H NMR spectrum of the polyglycidol-alanine ethyl ester conjugate. 
As this conjugation reaction can be carried out at room temperature in aqueous solution without 
addition of a catalyst, it fulfills perfectly the criteria of a “Click-type reaction” according to Sharpless 
et al.8 Therefore, the conjugation reaction seems perfectly suitable for the use in different 
biomedical applications, e.g. the synthesis of hydrogels with incorporated bioactive compounds or 
the use as scaffolds in tissue engineering which will be reported in the upcoming chapters. 
  
Chapter 4: Reactivity of Vinyl Sulfonate Terminated Polyglycidols  
 
52 
4.4 Conclusion 
The high reactivity of linear and star-shaped vinyl sulfonate terminated PG was shown by model 
reactions with various amines, amino acids and alcohols in different solvents. It was clearly proven 
that the conjugation occurred by addition of the nucleophile to the vinyl bond rather than 
elimination of the hydroxy group. 
In organic solvents, vinyl sulfonate terminated PEEGE is able to form conjugates with amines at room 
temperature without the addition of any catalyst. Furthermore, alcohols can be conjugated to the 
polymers as well by formation of the alcoholate prior to the conjugate addition reaction.  
In aqueous solution, amino acids can be conjugated to vinyl sulfonate terminated PG at room 
temperature under slightly basic conditions. All formed conjugates were characterized in detail by 
NMR spectroscopy. 
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Chapter 5: Degradable and Non-degradable Hydrogels Based on Vinyl 
Sulfonate Terminated Star-shaped Polyglycidols 
 
5.1 Introduction 
Hydrogels, cross-linked networks of water-soluble polymers, have gained rising interest during the 
last decades due to their unique properties, e.g. high porosity or generally high biocompatibility. 
Since the first report on the use of hydrogels for biological applications in the 1960s, hydrogels were 
commonly used for all kind of biomedical applications.1-3 Both biodegradable and non-biodegradable 
hydrogels are widely in use in drug delivery as well as for tissue engineering applications.4-7 Their 
porosity permits loading of drugs and their subsequent release which can be accelerated using 
biodegradable hydrogels.8, 9 Additionally, they provide a hydrophilic environment which can protect 
the loaded bioactive molecules from degradation.10, 11 
The use of different addition reactions for the generation of hydrogels on various length scales has 
gained increasing importance within the last years. Degradable hydrogels based on end group 
functionalized, star-shaped poly(ethylene glycol) (PEG) and peptides have been synthesized by 
conjugation addition reactions involving the vinyl sulfone end group of the polymer and the cysteine 
moiety of the peptide.12-15 Enzymatically degradable hydrogels based on PEG and poly(L-lysine) (PLL) 
were synthesized by formation of the network via carbamate chemistry.16 Recently, an excellent 
overview about the developments within the generation of hydrogels by addition reactions has been 
published.17 
During the last decade, polyglycidols (PGs) and their derivates have gained much attention in 
biomedical applications as an alternative to PEG due to their high functionality, solubility in aqueous 
media and biocompatibility. Furthermore, their ester derivates are generally recognized as safe 
(GRAS) by FDA.18-21 Several groups have studied the ring-opening multibranching polymerization of 
polyglycidol leading to dendritic structures.22-26 These highly branched structures have gained rising 
interest during the last years for various biomaterial applications.19, 27 Additionally, denritic 
polyglycidols have been used for the generation of particles on both nano- and micrometer scale.28, 29 
For the formation of hydrogels, the polymer has to be equipped with a highly reactive end group 
suitable to undergo reactions with the desired cross-linker. Different polymers equipped with 
maleimide groups, acrylamide groups, acrylate groups and vinyl sulfone groups have been reported 
showing a high reactivity towards the addition of thiols.12, 30-33 However, the introduction of these 
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reactive groups onto the polymer chain can be challenging and might end up with reaction mixtures 
due to crosslinking reactions.  
In the previous chapters, the synthesis of vinyl sulfonate terminated polyglycidols has been reported. 
These polymers show a high reactivity towards amines in both organic and aqueous solutions as 
shown in chapter 4.  
The goal of this investigation is the formation of hydrogels based on polyglycidol. As a polypeptide, 
poly(L-lysine) (PLL) showed no cytotoxicity depending on the molecular weight combined with 
biodegradability and can be cross-linked to form hydrogels.16, 34-36 Additionally, PLL does promote cell 
adherence and can be modified via the free amine group within the side chain, e.g. by introduction of 
peptides.37, 38 
In this chapter, the generation of both degradable and non-degradable hydrogels based on 
polyglycidol, their degradation behavior and their potential as drug delivery system will be reported. 
Furthermore, the formation of microgels based on polyglycidol will be shown as well. 
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5.2 Experimental Part 
Materials 
Dimethyl sulfoxide (DMSO), dichloromethane (DCM) and tetrahydrofuran (THF) have been purchased 
in analytical grade over molecular sieve from Sigma-Aldrich and used as received. Dioctyl 
sulfosuccinate sodium salt (AOT), dipentaerythritol, glycidol, triethylamine, potassium tert.-butoxide 
(1.0M in THF), poly(ethylene imine) (Mw = 25 000 g mol
-1), poly(L-lysine) (Mw = 22 000 g mol
-1), 
poly(allyl amine) solution (20 wt.% in water; Mw = 17 000 g mol
-1) and subtilisin Carlsberg (from 
Bacillus licheniformis; ca. 12 units mg-1) were purchased from Sigma-Aldrich and used as received. 
Trypsin (14 370 BAEE units mg-1) was purchased from Wako Chemicals and used as received.  
5-(Aminoacetamido)fluorescein was purchased from Invitrogen and used as received.  
2-Chloroethylsulfonyl chloride was purchased from Alfa Aesar and used without further purification. 
EEGE was synthesized according to literature procedure.39 All other chemicals were purchased at 
analytical grade from different suppliers. 
Polymer Synthesis 
The synthesis of the vinyl sulfonate terminated star-shaped polyglycidol has been described in detail 
in the chapters 3 and 4. Briefly, sPEEGE was synthesized using dipentaerythritol as initiator, 
ethoxyethyl glycidyl ether as monomer, potassium tert.-butoxide and DMSO in an anionic 
polymerization procedure. Afterwards, sPEEGE was reacted with 2-chloroethylsulfonyl chloride to 
obtain vinyl sulfonate terminated sPEEGE (VS-sPEEGE) and then the protecting group was removed 
by treatment with hydrochloric acid to obtain vinyl sulfonate terminated, star-shaped polyglycidol 
(VS-sPG). The resulting product was purified by dialysis against water. Size exclusion chromatography 
proved that no formation of dimmers took place and the molecular weight of approx. 5 000 g mol-1 
was determined. 
Synthesis of hydrogels based on vinyl sulfonate terminated polyglycidol and poly(L-lysine) 
Either 80 mg VS-sPG (0.016 mmol, 0.096 mmol in relation to vinyl sulfonate end groups) or 40 mg VS-
sPG (0.008 mmol respectively 0.048 mmol) were dissolved in 0.5 mL H2O. Afterwards, 40 mg poly( 
L-lysine) (0.0018 mmol, 0.2 mmol in relation to amine groups) was dissolved in 0.5 mL H2O and 50 µL 
Et3N was added. The solution was stirred at room temperature until gelation of the solution (approx. 
5-10 min). 
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Synthesis of hydrogels based on vinyl sulfonate terminated polyglycidol and poly(allyl amine) 
VS-sPG (80 mg, 0.016 mmol, 0.096 mmol in relation to vinyl sulfonate end groups) was dissolved in 
0.5 mL H2O. Afterwards, either 125 µL poly(allyl amine) solution (25 mg PAAm, 0.45 mmol in relation 
to amine groups) or 50 µL PAAm-solution (10mg PAAm, 0.2 mmol in relation to amine groups) 
dissolved in 0.5 mL H2O was added and the solution was stirred at room temperature until gelation of 
the solution.  
Synthesis of hydrogels based on vinyl sulfonate terminated polyglycidol and poly(ethylene imine) 
VS-sPG (80 mg, 0.016 mmol, 0.096 mmol in relation to vinyl sulfonate end groups) was dissolved in 
0.5 mL H2O. Afterwards, either 33 mg poly(ethylene imine) (0.003 mmol, 0.2 mmol in relation to 
amine groups) or 80 mg poly(ethylene imine) (0.008 mmol, 0.5 mmol in relation to amine groups) 
dissolved in 0.5 mL H2O was added and the solution was stirred at room temperature until gelation of 
the solution. 
Investigation of the swelling behavior 
Parts of freeze-dried hydrogels were weighted (WD) and then incubated in 5 mL H2O for 24 h. 
Afterwards the swollen gels were weighted again (WS). The amount of water in the gel was calculated 
by (WS-WD)/WS. The experiment was repeated three times to ensure reproducibility.  
Investigation of the influence of pH on the formation of hydrogels 
VS-sPG (80 mg, 0.016 mmol, 0.096 mmol in relation to vinyl sulfonate end groups) and 125 µL 
poly(allyl amine) solution (20 wt.%, 25 mg PAAm, 0.45 mmol in relation to amine groups) were 
dissolved in 0.5 mL H2O each. Afterwards, the pH value of both solutions was adjusted to pH = 5, 7, 8 
or 9. After mixing of the solutions with equal pH values, the gelation time for each pH value was 
measured. The experiment was repeated three times to ensure reproducibility. 
Cytotoxicity assay 
To exclude the release of toxic compounds from the hydrogels, the influence of the eluate on the 
growth of human fibroblasts was determined. After seeding of 300 000 human fibroblasts in 
RPMI1640 medium containing 10% FCS in a six well plate and incubation for 3 hours at 37 °C, parts of 
equal size of the hydrogels were added to the medium and incubated for 24 h. Afterwards, the 
culture medium as well as the hydrogels were removed followed by addition of 500 µL new culture 
medium and 50 µL Alamar blue. Incubation was continued for another 2 h at 37 °C. 2 x 100 µL of the 
medium were transferred to a 96 well plate and fluorescence of the samples was measured using an 
Optima Fluorescence Reader at 544 nm. As reference, the influence of tissue culture polystyrene 
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(TCPS) on the growth of fibroblasts was determined. The experiment was repeated three times to 
ensure reproducibility. 
Biodegradation of hydrogels 
10 mg of freeze-dried gel was incubated in H2O for 24 hours. Afterwards, swollen gels were 
transferred into a petri dish and immersed into 2 mL trypsin solution (0.1 mg Trypsin per mL H2O; 
1430 units mL-1) at 25 °C. Hydrolysis of the hydrogels was observed by eye. Degradation time was 
defined as the period required for complete transition.  
Synthesis of dye loaded, degradable and non-degradable hydrogels 
VS-sPG (80 mg, 0.016 mmol, 0.096 mmol in relation to end group) was dissolved in 200 µL H2O. 
Afterwards, 0.05 mL Et3N followed by 40 µg 5-(aminoacetamido)fluorescein (0.1 µmol) dissolved in 
H2O was added and the solution was stirred for 15 min at room temperature to allow formation of 
the dye-polymer conjugate. For degradable hydrogels, 40 mg poly(L-lysine) (1.8 µmol, 0.2 mmol in 
relation to amine groups) was added. For non-degradable hydrogels, 50 µL PAAm-solution (10 mg 
PAAm, 0.2 mmol in relation to amine groups) was added. Afterwards, the solution was stirred at 
room temperature until gelation of the solution (approx. 5-10 min) resulting in a hydrogel with a dye 
content of 0.33 µg dye per mg dry hydrogel for VS-sPG:PLL gels and a content of 0.44 µg dye per mg 
dry hydrogel for VS-sPG:PAAm gels. 
Investigation of the release of 5-(aminoacetamido)fluorescein 
Samples of dye-loaded, degradable VS-sPG:PLL hydrogels as well as samples of dye-loaded, non-
degradable VS-sPG:PAAm hydrogels were incubated either in 2 mL water or in 2 mL trypsin solution 
(0.1 mg Trypsin per mL H2O / 1430 units mL
-1) for up to 24 hours at 25 °C. The released amount of 5-
(aminoacetamido)fluorescein has been determined after 0,5,10,30,60,120,180 & 240 min as well as 
after 24 h using a micro plate reader. The experiment has been repeated three times to ensure 
reproducibility. 
Immobilization of subtilisin Carlsberg via covalent bonding 
VS-sPG (80 mg, 0.016 mmol, 0.096 mmol in relation to end group) was dissolved in 200 µL H2O. 
Afterwards, 0.05 mL Et3N followed by 3 mg subtilisin Carlsberg dissolved in 200 µL H2O was added 
and the solution was stirred for 15 min at room temperature to allow formation of the enzyme-
polymer conjugate. Finally, 50 µL PAAm solution (20 wt.%, 10 mg PAAm, 0.2 mmol in relation to 
amine groups) was added and the solution was stirred at room temperature until gelation of the 
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solution (approx. 5-10 min) resulting in a hydrogel with a loading of 33 µg enzyme per mg of dry 
hydrogel.  
Activity of subtilisin Carlsberg loaded hydrogels 
The activity of free and hydrogel-bound SC was determined according to a literature known 
procedure.40 In general, 1 mg of dry SC-loaded hydrogel containing 33 µg enzyme was swollen in  
1 mL H2O. As a reference, a solution of 330 µg free SC in 10 mL H2O was prepared. The substrate 
solution was prepared by dissolving 2 mg succinyl-Ala-Ala-Pro-Phe-p-nitroanilide in 12.8 mL PBS 
resulting in a 0.25 mM solution. For the determination of the activity, either the hydrogel or 1.0 mL 
of the reference solution was mixed with 1.0 mL of the substrate solution. After 5 min, the cleavage 
of the substrate was determined by UV-VIS spectroscopy. 
Formation of microgels based on VS-sPG and PAAm or PLL 
VS-sPG (40 mg, 8 µmol respectively 48 µmol) was dissolved in 250 µL H2O. Furthermore, 400 mg 
dioctyl sulfosuccinate sodium salt was dissolved in 30 mL pentane and the VS-sPG solution was 
added under vigorous stirring. After 10 min, either 20 mg PLL (0.1 mmol in relation to amine groups) 
dissolved in 250 µL H2O or 25 µL PAAm solution (20 wt.%, 5 mg PAAm, 0.1 mmol in relation to amine 
groups) diluted with 225 µL H2O was added. The solution was stirred over night. Afterwards, stirring 
was stopped and the aqueous phase was separated. The particles were isolated by freeze drying, 
redispersed in H2O, purified by dialysis against H2O for 2 days to remove remaining AOT and then 
freeze-dried again. 
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5.3 Results and Discussion 
In Chapter 4, the conjugation addition reaction in water between VS-sPG and molecules bearing one 
amine group has been described in detail. For the synthesis of hydrogels, the amount of amine 
groups has to be increased to allow the formation of networks within the formed conjugate. 
Therefore, the use of di-, tri- and polyamines has been investigated. 
5.3.1 Crosslinking with di-, tri- and polyamines 
Theoretically, crosslinking of vinyl sulfonate terminated star-shaped polyglycidols should be possible 
with a difunctional molecule as the polymer itself already carries six functional groups. Therefore, 
first cross linking experiments have been carried out with 2,2’-(ethylenedioxy)bis(ethylene amine) as 
a diamine. Unfortunately, no gelation of the solution was observed. Further increase of the 
functionality of the cross linker to a triamine did not lead to hydrogel formation as well.  
Therefore, the number of amine moieties had to be increased and reactions with three different 
multiamines, poly(ethylene imine) (PEI), poly(allyl amine) (PAAm) and poly(L-lysine) (PLL), were 
investigated for the synthesis of hydrogels. For all three polymers, stable hydrogels were obtained 
depending on the ratio between amine groups and vinyl sulfonate end groups as shown in Table 5-1.  
Table 5-1: Overview of hydrogels derived from VS-sPEEGE and different amounts of various (poly)amines. 
(Poly)amine weight ratio 
VS-sPEEGE:PA 
ratio 
VS:NH2 
gelation 
2,2’-(ethylene-
dioxy)bis(ethylene 
amine) 
10:1 1:2 no 
 5:1 1:4 no 
poly(L-lysine) 2:1 1:2 yes 
 1:1 1:4 yes 
poly(allyl amine) 8:1 1:2 yes 
 3.2:1 1:4 yes 
poly(ethylene 
imine) 
2.6:1 1:2 yes 
 1:1 1:5 yes 
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In Figure 5-1, a VS-sPG:PEI hydrogel with a weight ratio of 1:1 and a ratio between amine groups and 
vinyl sulfonate groups of 5:1, is shown exemplarily. 
 
Figure 5-1: Hydrogel based on VS-sPG and PAAm. 
For tissue engineering applications, the maximum water content of the different hydrogels is one of 
the most important properties as it is very important for the cell growth. Therefore, the amount of 
water of the swollen hydrogels has been determined as summarized in Figure 5-2. 
 
Figure 5-2: Amount of H2O in VS-sPG:PEI, VS-sPG:PAAm and VS-sPG:PLL hydrogels, n = 3. 
Hydrogels containing PEI showed a relatively low water content of approx. 65 wt.% in the equilibrium 
swollen state. Hydrogels containing PAAm were able to reach a water content of more than 80 wt.% 
while PLL containing hydrogels consist to more than 95 wt.% of water and therefore are most 
promising for cell culture applications. 
One major drawback using polycations, e.g. PEI or PAAm, as building blocks of hydrogels for the use 
in biomedical applications is the usually high cytotoxicity of the polymer. To determinate the toxicity 
of the hydrogels, the influence of the eluate from the different gels on the growth of fibroblasts has 
been investigated. The results are shown in Figure 5-3. 
Chapter 5: Degradable and Non-degradable Hydrogel  
63 
 
Figure 5-3: Influence of elute of different hydrogels on the growth of fibroblast after 24h growth, n = 3. 
It is obvious that hydrogels containing either PEI or PAAm showed a high toxicity. In contrast, 
hydrogels containing PLL as building block showed only minor influence on the growth of fibroblasts. 
In general, PEI containing hydrogels seemed not suitable for the use in biomedical applications due 
to the high cytotoxicity combined with low water uptake. Therefore, further investigations were 
carried out either with VS-sPG:PAAm or VS-sPG:PLL hydrogels which both seemed more suitable for 
the desired applications. 
5.3.2 Kinetics of hydrogel formation 
Beside water content and cytotoxicity, the kinetics of the formation of the hydrogel is important as 
well for the usage in biomedical applications. In principal, hydrogels were formed by conjugate 
addition reaction of the vinyl sulfonate end groups of VS-sPG and the amine groups of PAAm or PLL 
similar to the described model reactions in chapter 4. The addition of nucleophiles to unsaturated 
double bonds, often referred to as Michael-type reaction, is known to be strongly pH depended. 
Therefore, the influence of the pH on the gelation of VS-sPG:A PAAm gel was investigated. PAAm has 
been chosen as model substance due to the easy availability of the material, but no significant 
differences in the gelation times between PAAm and PLL or PEI has been found in earlier 
investigations. The gelation time in relation to the pH value has been summarized in Figure 5-4. 
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Figure 5-4: Time for complete gelation of VS-sPG:PAAm hydrogels in relation to the pH value, n = 3. 
While no gelation of the solution was observed for pH values below 7, the gelation time decreased 
dramatically from 140 min in neutral milieu to approximately one minute at pH = 9. This is in good 
agreement with theoretical expectations as Michael-type addition reactions are much faster under 
basic conditions. Especially for applications involving living cells or peptides, high pH values should be 
avoided as basic conditions might cause serious damage to the biological compounds. Therefore, a 
pH value of 8 seems to be a good compromise between biocompatibility and fast gelation of the gel. 
5.3.3 Biodegradable hydrogels based on poly(L-lysine) 
Biodegradable hydrogels are very interesting for different types of applications, e.g. for drug delivery 
or as scaffold for tissue engineering. Hydrogels containing poly(amino acids), e.g. PLL, can be 
degraded by hydrolytic enzymes, e.g. trypsin, as shown for lysine containing PEG hydrogels.34, 35 
Similar to PEG, VS-sPGs are not biodegradable and thus will not degrade upon treatment with 
enzymes. Therefore, the kinetics of degradation are expected to be dependent on the amount of PLL 
which furthermore corresponds with the cross linking degree inside the gel due to the different 
amine to vinyl sulfonate ratios. Two hydrogels with different VS-sPG:PLL amounts were synthesized 
and the biodegradation was investigated by incubation in a solution containing 1400 units trypsin per 
mL H2O. The degradation could be observed easily by eye as seen in Figure 5-5 and Figure 5-6. 
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Figure 5-5: Biodegradation of VS-sPG:PLL 2:1 (w/w) hydrogel after 0 h (left), 3 h (center) and 4 h 
(right) incubation in trypsin solution (1400 units mL-1). 
 
Figure 5-6: Biodegradation of VS-sPG:PLL 1:1 (w/w) hydrogel after 0 h (left), 4 h (center) and 20 h 
(right) incubation in trypsin solution (1400 units mL-1). 
The VS-sPG:PLL 2:1 gel was degraded completely within 4 hours while the VS-sPG:PLL 1:1 gel needed 
approx. 20 h for complete degradation. One reason for the slower degradation of the latter gel might 
be the higher poly(L-lysine) amount. Despite the fact that the latter one has a higher ratio between 
amine and vinyl sulfonates and therefore is expected to be less cross linked than the first one, it 
showed slightly lower swelling ability and therefore less accessibility of the cleavable amide bond by 
the trypsin which might be an additional reason for the slower biodegradation. 
Hydrogels containing poly(allyl amine) instead of poly(L-lysine) as a non-degradable polyamine did 
not show any degradation behavior upon treatment with trypsin solution (not shown here), 
indicating the degradation of the gel by cleavage of the amide bonds of the PLL component and not 
at the vinyl sulfonamide moieties. 
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5.3.4 Loading and release of a model substance from degradable hydrogels 
Biodegradable hydrogels are especially interesting as drug carriers as they are able to release a drug 
during degradation. To investigate the potential of VS-sPG:PLL hydrogels for drug delivery 
applications, an amine containing fluorescent dye, 5-(aminoacetamido)fluorescein, was used as a 
model substance. The hydrogel was loaded by a two-step process: first the dye-polymer conjugate 
was formed by reaction of the desired amount of 5-(aminoacetamido)fluorescein with VS-sPG and 
then the conjugate was reacted with either PLL or PAAm to form both degradable and non-
degradable hydrogels. Using this procedure, the dye has been incorporated to the hydrogel by 
covalent bonding and therefore can only be released by degradation of the gels and not by diffusion. 
The release of the fluorescent dye has been monitored by UV-VIS spectroscopy. The results were 
shown in Figure 5-7. 
 
Figure 5-7: Comparison of the release of 5-(aminoacetamido)fluorescein from VS-sPG:PLL and VS-sPG:PAAm hydrogels with 
and without enzymatic cleavage of the hydrogel. 
Treatment of the loaded hydrogel with trypsin solution led to complete release of the dye within four 
hours due to the enzymatic degradation of the hydrogel. Treatment of the hydrogel with water 
instead of trypsin solution led to a significantly slower release behavior indicating the slower 
hydrolytic cleavage of the gel. In contrast, investigation of the release of the fluorescent dye 
entrapped in a non-degradable hydrogel based on VS-sPG and PAAm showed no release both for the 
treatment with trypsin solution and water which indicates that a release of the dye is only possible 
by the degradation of the hydrogel matrix and not by diffusion of the dye through the hydrogel. 
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5.3.5 Immobilization of subtilisin Carlsberg inside non-biodegradable hydrogels 
One drawback for the use of bioactive compounds, e.g. enzymes, within biological systems is their 
fast degradation. One possibility to overcome this problem is the loading of the enzyme inside a non-
biodegradable hydrogel which provides a hydrophilic environment and shields the compound. 
However, efficiency of the peptide might be significantly lowered by the hydrogel with low water 
contents. To investigate the potential of VS-sPG based hydrogels as carrier substances, subtilisin 
Carlsberg (SC) as model enzyme has been chosen. Subtilisins as non-specific protease originally 
obtained from Bacillus subtilis are widely used in various commercial products, e.g. laundry 
detergents. The activity of subtilisin can be easily monitored by the cleavage of succinyl-Ala-Ala-Pro-
Phe-p-nitroanilide using UV-VIS spectroscopy.40 Non-degradable hydrogels based on VS-sPG and 
PAAm have been loaded with 3.3 wt.% SC and the reactivity of the hydrogel-enzyme conjugate was 
compared to the reactivity of the same amount of free enzyme. The results are summarized in Figure 
5-8. 
 
Figure 5-8: UV-VIS spectra of succinyl-Ala-Ala-Pro-Phe-p-nitroanilide prior to (black) and after treatment with enzyme-
loaded hydrogel (green) and free enzyme (red) respectively. 
As seen in the change of the spectra of the succinyl-Ala-Ala-Pro-Phe-p-nitroanilide prior and after 
treatment with the enzyme-hydrogel conjugate, the activity of SC was maintained within the 
hydrogel matrix. Compared to treatment with free enzyme, the enzyme-loaded hydrogel was slightly 
less active than non-bound SC but still showed high reactivity. One potential explanation for the 
slightly lower activity might be the shielding effect of the hydrogel which influences the transport of 
the substrate to the enzyme. 
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Beside the protection of the enzyme from degradation, an additional advantage of enzyme loaded 
hydrogels is their potential reusability. While it is very difficult to recover free enzymes from a 
solution, a hydrogel can be easily separated from a solution by filtration. Therefore, the activity of 
the SC-loaded hydrogels was investigated by comparison of the adsorption at 384 nm of the UV-VIS 
spectra after several usage cycles and compared with the activity after the first use. The results of 
this investigation are summarized in Figure 5-9. 
 
Figure 5-9: Activity of SC-loaded hydrogel after multiple use in relation to the activity of first time use. Activity determined 
by UV-VIS spectroscopy at 384 nm. 
As shown by UV-VIS spectroscopy, the enzyme inside the hydrogel is still active after multiple usage 
steps up to 20 times. None the less, the decrease of activity can only be explained by either a release 
of the enzyme from the hydrogel indicating a non-covalent loading inside the hydrogel or by 
degradation of the enzyme after multiple treatments. For clarification of this effect, further 
investigations have to be made. 
5.3.6 Formation of Microgels based on VS-sPG and PAAm or PLL 
Hydrogel particles with a diameter less than 100 µm, so-called microgels, as well as particles in the 
sub-micron range, so-called nanogels, have gained rising interest during the last years for usage in 
various fields of biomedical applications.17, 41, 42 Especially the use of addition reactions for the 
formation of small hydrogel particles seems to be very promising.17 Therefore, the potential of the 
addition reaction between VS-sPG and PAAm resp. PLL to form small particles was investigated. 
An inverse emulsion system was established by stabilizing a solution of VS-sPG dissolved in water in 
heptane with dioctyl sulfosuccinate sodium salt (AOT) as emulsifier. Afterwards, PAAm resp. PLL 
Chapter 5: Degradable and Non-degradable Hydrogel  
69 
dissolved in H2O was added drop wise to the inverse emulsion system under rigorous stirring. 
Coalescence of droplets of the two different aqueous solutions led to addition reaction resulting in 
small size hydrogel particles which were analyzed by FESEM as shown in Figure 5-10 and Figure 5-11. 
  
Figure 5-10: FESEM pictures of microgels based on VS-sPG and PAAm (4:1 w/w). 
  
Figure 5-11: FESEM pictures of microgels based on VS-sPG and PLL (2:1 w/w). 
For both polyamines, particles with a diameter between 5 to 10 µm could be obtained. In general, 
the particles showed no significant difference of size or shape in relation to the polyamine used. 
In section 5.3.3, the biodegradation of VS-sPG:PLL hydrogels was investigated and fast degradation 
could be observed by treatment with trypsin solution. A similar degradation behavior was expected 
for the microgels and therefore VS-sPG:PLL microgels were treated with trypsin solution and then 
analyzed by FESEM as shown in Figure 5.12. 
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Figure 5-12: FESEM picture of VS-sPG:PLL based microgels after 4 h treatment with H2O (left) or trypsin solution (1400 units 
mL
-1
) (right). 
While the microgels showed no significant change in size and shape after incubation in H2O, similar 
microgels treated with trypsin solution were completely degraded after 4 h. Therefore, they seem to 
have a great potential as carriers for drug delivery. 
 
5.4 Conclusion 
Stable hydrogels based on vinyl sulfonate terminated star-shaped polyglycidol could be formed using 
poly(ethylene imine), poly(allyl amine) or poly(L-lysine) as second component. The water content of 
the hydrogels ranged from 65 wt.% for PEI based gels to up to 95 wt.% for gels based on PLL. 
PLL based gels showed low cytotoxicity and could be degraded completely by treatment with trypsin. 
Loading of the gels with a fluorescent dye as a model substance followed by investigation of the 
release behavior showed a near complete release within 4 hours when treated with trypsin 
compared to a slower release upon treatment with water. PAAm based gels could be successfully 
loaded with subtilisin Carlsberg as a model enzyme maintaining the activity of the enzyme inside the 
hydrogel.  
Furthermore, hydrogel particles based on VS-sPG and PLL or PAAm with a diameter of approx. 5 µm 
to 10 µm could be prepared by an inverse emulsion system using AOT as stabilizer. Investigation of 
the degradation behavior of VS-sPG:PLL microgels showed complete degradation of the gels within 4 
hours similar to the results for bulk hydrogels. 
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Chapter 6: Electrospun Fibers Based on Vinyl Sulfonate Terminated Star-
Shaped Poly(ethoxyethyl glycidyl ether)4 
 
6.1 Introduction 
Nonwoven fiber meshes for tissue engineering applications have gained great interest during the last 
decade. Especially bioresorbable materials, e.g. poly(α-hydroxy acids), are widely used in biomedical 
applications.1 Poly(ε-caprolactone) (PCL) as a representative of this group is often used where slow 
degradation is favorable. Unfortunately, pure PCL readily adsorbs proteins influencing strongly the 
biomaterial – tissue interaction. One possibility to overcome this limitation is the increase of the 
hydrophilicity of the material to reduce the unspecific protein adsorption. A range of biomaterials 
can be tailored to be resistant to non-specific protein adsorption by surface modification with 
poly(ethylene glycol) (PEG) to the substrate.2-4 Ultra thin functional networks of star-shaped PEG 
were shown to be extremely resistant to unspecific adsorption of proteins.5-7 
None the less, many polymers as potential alternatives to PEG are currently under investigation. 
Polyglycidols (PGs) fulfill all structural prerequisites to replace star-shaped PEGs in biomedical 
application and exceed the possibilities due to their high intrinsic functionality and the possibility to 
adjust the functionality to the demands of the application. As most synthetic polymers have no 
functional groups attached to the polymer main chain, PGs with hydroxy side groups and its 
derivatives are of great interest for various applications in medicine because of their high 
functionality, solubility in aqueous media and biocompatibility.8-11 Therefore, several groups have 
studied the ionic polymerization of glycidol leading to branched polymers during the last  
decades.8, 12-15 In general, the microstructure of the hyperbranched PGs cannot be well controlled. To 
obtain architecturally well defined PG, the hydroxy group of the monomer has to be protected with a 
suitable protecting group leading to highly defined polymers with narrow distributions. Mostly 
ethoxyethyl glycidyl ether (EEGE) is used for the preparation of PG with controlled architecture since 
the protecting group is easily removed from the polymer under acidic conditions. Therefore, anionic 
polymerization of the protected monomer followed by removal of the protecting group yields 
polyglycidol with well-defined architecture.11, 16-20 
In chapter 3, the synthesis of vinyl sulfonate terminated star-shaped poly(ethoxyethyl glycidyl ether) 
(VS-sPEEGE) has been reported. Star-shaped polymers were used for further increase of the 
                                                          
4
 Results within this chapter have been published in the following article:  
D. Haamann, M. Bispinghoff, D. Hönders, C. Suschek, M. Möller, D. Klee, Electrospun Fibers from functional 
Polyglycidol/Poly(ε-caprolactone) Blends with Defined Surface Properties, Journal of Applied Polymer Science 
2012, 125, 3638-3647 
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functionality. These polymers have great potential for their usage in polymer/protein or 
polymer/peptide conjugates due to their unique reactivity towards amines as reported in chapter 4. 
Furthermore, they can be used as precursors for the introduction of different moieties, e.g. alkyne 
groups, for the use in copper(II)-catalyzed alkyne-azide coupling reactions which have gained 
tremendous interest during the last years due to high efficiency combined with mild reaction 
conditions. None the less, the use of the highly toxic copper(II) as catalyst remains an unsolved 
problem for biological applications.21, 22 
Electrospun nanofibers have been extensively investigated for their use in biomedical applications 
during the last years. As this process has been comprehensively discussed in literature, detailed 
information on the electrospinning process can be found elsewhere.23-25 Electrospun fibers mimic the 
dimension of fibrous proteins (fibrils) found in extracellular matrices, therefore they allow infiltration 
of the cells into the matrix followed by proliferation.26, 27 Further functionalization of the fibers, e.g. 
with the bioactive peptide sequence glycine-arginine-glycine-aspartate-serine (GRGDS), led to a 
controlled cell interaction with the electrospun fibers.28 The usage of end group functionalized 
polymers in the electrospinning process allows the preparation of reactive electrospun  
nonwoves.25, 29 While the usage of reactive PEO/PCL blends or PEO-b-PCL copolymers to produce 
hydrophilic electrospun nonwovens has already been published, the use of polyglycidol for this 
purpose has not been reported yet.30-32 Additionally, only few studies concerning the electrospinning 
of hyperbranched PG has been published till now.33-36  
As sPEEGE is a highly viscous polymer, stable nanofibers could only be obtained from polymer blends 
containing a second polymer. Due to its high biocompatibility as well as miscibility with sPEEGE, PCL 
was used to produce nonwovens. Especially the synthesis of nanofibers based on end-group 
functionalized star-shaped PEEGE and PCL by electrospinning is of great interest due to the possibility 
of direct functionalization with bioactive molecules. These nonwovens are expected to be 
advantageous for many kinds of different applications, e.g. for tissue engineering. 
In this chapter, the electrospinning of polymer blends containing star-shaped poly(ethoxyethyl 
glycidyl ether) and poly(ε-caprolactone) (sPEEGE/PCL) with up to 35 wt.% sPEEGE towards the 
generation of hydrophilic nonwovens with minimized unspecific protein adsorption will be reported. 
Furthermore, the use of alkyne or vinyl sulfonate end group functionalized sPEEGEs lead to 
nonwovens with high specific surface reactivity. These fibers can further be functionalized with 
bioactive molecules on their surface to control cell-interface interactions.  
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6.2 Experimental Part 
Materials 
Poly(ε-caprolactone) (Mw=65 000 g mol
-1, PDI = 1.4) was purchased from Sigma-Aldrich and used as 
received. Chloroform and methanol was purchased from VWR International. Alexa Fluor® 488 azide, 
deuterochloroform, copper(II) sulfate, dimethyl sulfoxide, dipentaerythritol, potassium tert.-butoxide 
and PBS buffer solution were purchased from Sigma-Aldrich. (R)-(-)-4-(3-Aminopyrrolidino)-7-nitro-
benzofuran was purchased from Fluka. 2-Chloroethylsulfonyl chloride was purchased from Alfa 
Aesar. BSA BODIPY® FL conjugate was purchased from Invitrogen and sodium ascorbate was 
purchased from Merck. All other chemicals were purchased from different suppliers. All chemicals 
were used without any further purification.  
Synthesis of sPEEGE, VS-sPEEGE and alkyne-PEEGE 
The synthesis of the vinyl sulfonate terminated star-shaped polyglycidol has been described in detail 
in chapter 3. Briefly, sPEEGE (Mw = 14 500 g mol
-1, PDI = 1.1) was synthesized using dipentaerythritol 
as initiator, ethoxyethyl glycidyl ether as monomer, potassium tert.-butoxide and DMSO in an anionic 
polymerization procedure. Afterwards, sPEEGE was treated with 2-chloroethylsulfonyl chloride to 
obtain VS-sPEEGE (Mw = 14 800 g mol
-1, PDI = 1.1). Alkyne terminated, star shaped PEEGE  
(Mw = 15 000 g mol
-1, PDI = 1.1) was prepared by reaction of VS-sPEEGE with 6 eq. propargylamine 
under basic conditions similar to conjugation procedures reported in chapter 4. All synthesized 
polymers were characterized by NMR and SEC prior to use. 
Electrospinning  
For electrospinning sPEEGE/PCL polymer blends with different sPEEGE amounts (0 wt.%, 15 wt.%,  
25 wt.%, 35 wt.% in relation to the total polymer amount) were dissolved in a mixture of chloroform 
and methanol (75/25, v/v) to produce 15 wt.% solutions (10 wt.% for the pure PCL solution). Unless 
otherwise noted, the polymer solution was pumped to the 18-gauge, flat-tipped, stainless steel 
spinneret at a rate of 0.4 mL h-1 connected to a voltage source of 15 kV. The fibers were either 
collected on silicon wafers fixed to an aluminum SEM stup (diameter 12 mm) or on a grounded 
aluminum cylinder (diameter 80 mm, length 25 mm), rotating at 200 rpm, both at a 150 mm distance 
from the tip of the spinneret. 
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Proof of surface reactivity 
Electrospun fibers produced from alkyne-functionalized sPEEGE were incubated for 24 h at room 
temperature in an aqueous solution of an azide-functionalized Dye (Alexa Fluor® 488 azide) (50 nmol 
mL-1), copper(II) sulfate (2.5 pmol mL-1) and sodium ascorbate (10 pmol mL-1) according to the well 
known Huisgen-Sharpless-Meldal reaction.21, 22 Afterwards, the samples were washed twice with 
distilled water. For the proof of the reactivity of the vinyl sulfonate end groups, electrospun 
nonwovens were incubated in a solution of (R)-(-)-4-(3-Amino¬pyrrolidino)-7-nitro-benzofuran 
(50 µg mL-1) in water for 1 h at room temperature. Afterwards the samples were washed twice with 
distilled water and then twice with ethanol. All samples were kept in the dark during all incubation 
and washing steps prior to analysis with fluorescence microscopy. 
Contact angle measurement 
Contact angle were determined by sessile drop measurements with a geniometer G40 (Krüss, 
Hamburg, Germany), using electrospun meshes collected on rotating drum. The volume of the 
applied droplet is 5 µL. The resulting value of each single measurement is the average value of the 
left and the right contact angle. For each sample, 5 droplets were measured for determination of the 
contact angle. The presented data are the average values of five measurements. Errors were 
determined through evaluation of the standard derivation of the measurements.  
Protein adsorption 
Electrospun fibers were incubated for 20 min in a solution of BODIPY® labeled bovine serum albumin 
(50 µg mL-1) in PBS buffer solution. Afterwards the samples were washed twice with PBS buffer 
solution and then washed twice with distilled water. All samples were kept in the dark during all 
incubation and washing steps prior to analysis with fluorescence microscopy.  
NMR analysis 
NMR spectra of the fibers were collected on a Varian Mercury 300 MHz NMR spectrometer. For the 
measurements, 8 mg of the electrospun nonwovens were solved in 0.7 mL deuterochloroform 
containing TMS as internal standard.  
SEM and optical microscopy 
The samples were imaged with SEM (S-4800 Ultra High Resolution Scanning Electron Microscope, 
Hitachi, Tokyo, Japan) using an accelerating voltage of 1 kV. Microscope images were taken with an 
Axioplan 2 (Zeiss, Oberkochen, Germany). 
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Cytotoxicity assay 
The potential cytotoxicity of the nonwoven was evaluated against primary human skin fibroblasts. 
The cytotoxicity assay was performed incubation of electrospun nonwoven within a fibroblast cell 
culture in a six well plate. The investigation of the cell growth had been performed as follows: first, 
15 000 cells/well were incubated in RPMI1640 medium containing 10% FCS for 4 hours. Afterwards, 
new cell medium as well as the electrospun nonwoven (approx. 1x1 cm2) was added to the cells and 
they were incubated at 37 °C for 48 h. As control, cell medium without nonwoven was used. 
Alamar¬blue was added (100 µL mL-1 medium) and incubation was continued for another 2 h at 37 
°C. 2x100 µL of the medium were transferred to a 96 well plate and fluorescence of the samples was 
measured using an Optima Fluorescence Reader at 544 nm.  
Immobilization of GRGDS on electrospun fibers and investigation of cell behavior  
For investigation of the cell growth, glass samples were coated with NCO-sP(EO-stat-PO) by literature 
known procedure to suppress cell growth on the substrate.26, 37 Afterwards, fibers from vinyl 
sulfonate terminated sPEEGE/PCL blends (25/75 w/w) were electrospun on coated glass slides. The 
fibers were incubated 30 min in H2O and then in an aqueous solution of 50 µg mL
-1 GRGDS for 1 h. 
Non-bound GRGDS was removed by washing twice with PBS buffer solution followed by washing 
twice with H2O. 
For the investigation of the interaction between the cells and the modified surface, 20 000 human 
dermal fibroblast cells in 1 mL Dulbecco modified eagle medium (DMEM) with 1% fetal bovine serum 
were seeded on the fibers and then incubated up to 96 hours at 37 °C and 95% humidity. Cell growth 
was determined using an optical microscope. 
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6.3 Results and Discussion 
The morphology and quality of the fibers strongly depends on the processing parameters (e.g. flow 
rate or voltage), the ambient parameters (e.g. air humidity or pressure) and the solution para-
meters.38 Especially the latter ones influences the interaction of the polymer chains during the 
electrospinning process and therefore the quality of the electrospun fiber. Furthermore, the ratio 
between PCL and sPEEGE does strongly determine the solution parameter and the quality of the 
formed fibers. 
In the first part of this chapter the influence on the fiber quality and their ability to minimize protein 
adsorption by variation of the ratio between the polymers is under investigation. In the second part 
surface reactive nanofibers are prepared using functionalized sPEEGEs followed by conjugation 
reaction with GRGDS. Finally, the cell behavior on the fibers is under investigation. 
6.3.1 Electrospinning of sPEEGE/PCL Blends with Different sPEEGE amount 
To investigate the influence of the sPEEGE amount on the fiber formation, three different blends 
with 15, 25 and 35 wt. % sPEEGE were successfully electrospun and compared with pure PCL fibers. 
The obtained fibers were analyzed by optical microscopy (Figure 6-1) and electron microscopy 
(Figure 6-2) as well as by NMR spectroscopy (Figure 6-3). 
 
Figure 6-1: Optical microscope pictures of fibers from sPEEGE/PCL blends spun at an applied voltage of 15 kV and 15 cm 
distance with 15 wt.% (A), 25 wt.% (B) and 35 wt.% (C) sPEEGE amount and pure PCL fiber (D) as reference. 
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Figure 6-2: SEM-image of fibers from sPEEGE/PCL blends with 25 wt.% sPEEGE spun at an applied voltage of 15 kV and 15 
cm distance. 
All blends could easily be electrospun and resulted in smooth and homogeneous fibers of approx. 
200 – 300 nm fiber diameter. Investigation of the composition of the nonwovens by NMR spectrosco-
py showed good correspondence between the fibers and the spinning solution with slightly less 
amount of sPEEGE in the fiber compared to the polymer feed. 
 
Figure 6-3: 
1
H-NMR spectra of an electrospun nonwoven from a sPEEGE/PCL (15:25 w/w) polymer blend. 
For investigation of the protein repelling properties of the fibers, electrospun nonwovens were 
incubated in a solution of fluorescently labeled bovine serum albumin (BODIPY® BSA), washed 
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thoroughly and then the remaining proteins were determined by fluorescent microscopy as shown in 
Figure 6-4. 
 
Figure 6-4: Fluorescence images of electrospun sPEEGE/PCL blends with 0 wt.% (A), 15 wt.% (B), 25 wt.% (C) and 35 wt.% 
(D) sPEEGE amount after incubation with BODIPY® labeled BSA. 
Fibers with different sPEEGE amount showed tremendously decreased fluorescence compared to 
pure PCL fibers indicating a decreased protein adsorption on fibers. Fibers with 15 wt.% or 25 wt.% 
sPEEGE amount showed no detectable protein adsorption while fibers with 35 wt.% showed some 
minor protein adsorption. This might be due to the slightly increased fiber diameter and therefore 
higher surface area. Due to the lack of protein adsorption on the sPEEGE/PCL electrospun fiber 
surfaces, we believe that sPEEGE is enriched at the fiber surface. This effect was already observed for 
other copolymers containing both hydrophilic and hydrophobic monomers, e.g. PEG-b-PDLLA or PEG-
b-PCL.30, 31 
If sPEEGE is enriched at the surface, hydrophilicity of the electrospun nonwovens has to be 
significantly raised compared to pure PCL fiber meshes. Therefore, the contact angle of the fiber 
meshes against water indicating the hydrophilicity of the surface was determined (Figure 6-5). 
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Figure 6-5: Images of contact angle measurements on electrospun PCL nonwoven (left), sPEEGE/PCL (15:85 w/w) (middle) 
and sPEEGE/PCL (25:75 w/w) (right) nonwoven. 
The addition of 15 wt.% sPEEGE to the polymer blend decreased the contact angle of the electrospun 
nonwoven from 129° to 32° indicating the enrichment of the hydrophilic sPEEGE on the surface of 
the fibers. Higher amounts of sPEEGE led to slightly higher contact angles (up to 42°) and therefore 
decreased hydrophilicity, which is another explanation for the increased protein adsorption on fibers 
with 35 wt.% sPEEGE. In general, the high hydrophilicity of the electrospun fibers seems to be the 
major reason for the suppression of the protein adsorption. 
6.3.2 Electrospun Nonwoven with High Surface Functionality 
To obtain surface reactive nonwovens, sPEEGE with different end groups were electrospun. Alkyne-
terminated sPEEGE was synthesized starting from vinyl sulfonate terminated sPEEGE treated with 
propargylamine similar to reactions described in chapter 4 to introduce alkyne-moieties as end 
group. Afterwards, the fiber morphology was investigated by optical microscopy and the protein 
repelling properties were determined by incubation in BODIPY® BSA followed by fluorescent 
microscopy. In Figure 6-6, the results were shown exemplarily for alkyne-functionalized fibers. 
 
Figure 6-6: Left: optical microscope picture of fibers from sPEEGE/PCL blend with 25 wt.% alkyne-end capped sPEEGE 
electrospun at an applied voltage of 15 kV and 15 cm distance. right: fluorescence images of the same fibers after 
incubation with BODIPY® labeled BSA. For pure PCL fibers as reference see figure 6-4. 
For both fibers with alkyne or vinyl sulfonate end groups, nonwovens with homogeneous fibers and 
reduced protein adsorption were obtained 
The high reactivity of the alkyne functionalized fibers was proved by a Huisgen-Sharpless-Meldal 
reaction (often referred to as “click”-reaction) using an azide-functionalized dye (commercially 
available Alexa Fluor® 488 azide) under standard “click” conditions with copper (II) sulfate and 
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sodium ascorbate in aqueous solution. The immobilization of the dye on the surface was determined 
by fluorescence microscopy. The results are shown in Figure 6-7. 
 
Figure 6-7: Fluorescence image of fibers from sPEEGE/PCL blends with hydroxy end groups (left) and alkyne end groups 
(right) at the sPEEGE after click reaction. 
In contrast to fibers produced by using a sPEEGE/PCL blend with no functionality, the functionalized 
nonwoven reacted readily with the azide dye resulting in strongly fluorescent fibers. The usage of the 
click reaction for further functionalization of electrospun fibers showed tremendous advantages, but 
some drawbacks have to be mentioned as well. As the reaction is highly specific towards azides, no 
other functional groups are able to react with the fibers limiting the number of available reaction 
partners heavily. Furthermore, copper as catalyst still remains an unsolved challenge for click 
reactions in Life Science due to the high cytotoxicity of the catalyst. In chapter 4, a new ligation 
method using vinyl sulfonate terminated polyglycidol reacting readily with small molecules bearing 
different functional groups, e.g. amines, in a Michael-type addition reaction, is reported, which might 
be a potential alternative. 
Therefore, nonwovens produced by electrospinning of vinyl sulfonate terminated sPEEGE (VS-
sPEEGE) together with PCL are expected to show a high reactivity towards small molecules carrying 
an amine moiety. This was proved by incubation of the nonwoven in an aqueous solution of an 
amino-functionalized dye ((R)-(-)-4-(3-Aminopyrrolidino)-7-nitro-benzofuran) for one hour, followed 
by washing and detection of the dye by fluorescence microscopy as shown in Figure 6-8. 
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Figure 6-8: Fluorescence images of fibers from sPEEGE/PCL blends with hydroxy end groups (left) and vinyl sulfonate end 
groups (right) after incubation with (R)-(-)-4-(3-aminopyrrolidino)-7-nitro- benzofuran in water. 
Compared to a nonwoven consisting of non-functionalized sPEEGE, the one containing vinyl sulfonate 
terminated sPEEGE showed high fluorescence after incubation indicating the addition of the dye to 
the surface of the fibers. In both cases, the electrospun fiber meshes maintained the functionality of 
the deployed sPEEGE. Together with the minimized protein adsorption of the fibers, this offers a lot 
of different potential applications for such fiber meshes. 
6.3.3 Cytotoxicity Assay of Functionalized and Non-functionalized Nonwovens 
Especially for application in tissue engineering, high biocompatibility of the nonwovens is extremely 
important. The influence of the electrospun fibers on the growth of cells was investigated by 
incubation of human fibroblasts with the nonwoven for 48 h. The results of the in vitro cytotoxicity 
assay are shown in Figure 6-9. 
 
Figure 6-9: Results of the cytotoxicity assay of the functionalized and non-functionalized nonwoven extracts against primary 
human fibroblasts. 
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Neither the eluate of nonwovens containing vinyl sulfonate terminated sPEEGE nor the eluate of 
nonwovens containing non-functionalized sPEEGE, induced any toxic effects on the growth of human 
fibroblast cells, showing high cell viability.  
6.3.4 Biofunctionalization of the Electrospun Nonwoven and Their Cell Behavior 
To control the adsorption of cells on the electrospun fibers, the nonwovens were further 
functionalized by immobilizing GRGDS on the surface of the fibers. For this purpose, surface reactive 
fibers based on vinyl sulfonate terminated sPEEGEs were incubated in an aqueous solution of GRGDS 
overnight and then non-bound GRGDS was removed by washing. To ensure that the attached GRGDS 
does not influence the properties of the electrospun fibers, the contact angle of the nonwoven was 
determined (Figure 6-10). 
 
Figure 6-10: Images of contact angle measurements on electrospun PCL nonwoven (left) and GRGDS-sPEEGE/PCL (85:15 
wt.%) nonwoven (right). 
Furthermore, the protein repelling properties of the fibers were investigated by incubation in a 
solution of BODIPY® BSA, followed by determination of the fluorescence by microscopy similar to 
earlier experiments (Figure 6-11). 
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Figure 6-11: Fluorescence images of PCL (left) and GRGDS-sPEEGE/PCL fiber meshes (right) after incubation with BODIPY® 
labeled BSA. 
Both the results of the contact angle measurements as well as the results of the unspecific protein 
adsorption from fibers containing GRGDS were comparable to the results of fibers without GRGDS. 
Therefore, no influence of the fiber surface properties was observed by the immobilization of 
GRGDS. 
To investigate the cell behavior on the nonwovens, both GRGDS-functionalized and non-
functionalized electrospun nonwovens were incubated with human fibroblasts for up to 72 h. The 
growth of the cells was determined by optical microscopy as seen in Figure 6-12. 
 
Figure 6-12: Optical microscope pictures of the growth of human fibroblast cells on electrospun fibers with (A & D) and 
without (B & C) GRGDS immobilized on the surface after 48 h (A, B), and 72 h (C, D) growth time. 
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Only minor cell growth was observed on non-functionalized fibers. In contrast, on fibers equipped 
with GRGDS strong cell adhesion was observed indicating the successful immobilization of the 
peptide on the surface of the fiber influencing the interaction between cells and the surface of the 
fibers. 
 
6.4 Conclusion 
Electrospun fibers containing star-shaped poly(ethoxyethyl glycidyl ether) can be produced using a 
polymer blend together with poly(ε-caprolactone). Using an applied voltage of 15 kV and a distance 
of 15 cm, smooth and homogenous fibers were produced. The obtained electrospun fibers are water 
insoluble but hydrophilic as shown by contact angle measurements. The fibers showed a significant 
reduction of the unspecific protein adsorption depending on the content of sPEEGE in the polymer 
blend.  
The usage of reactive, end-group functionalized sPEEGE in the polymer blend led to fibers with high 
surface reactivity. These fibers were further functionalized with small molecules depending on their 
introduced reactivity. All fiber nonwovens did not show any influence of the growth of human 
fibrozytes. Finally, surface reactive electrospun nonwovens were successfully equipped with GRGDS 
showing an increased cell attachment on the fibers compared to non-functionalized ones. 
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Chapter 7: Hydrogel Coatings Based on Vinyl Sulfonate Terminated Star-
shaped Polyglycidols 
 
7.1 Introduction 
The interaction between artificial surface and biological systems is very important for various 
applications like implants or biomedical devices. To control these interactions, the unspecific protein 
adsorption on the surface has to be prevented. Furthermore, additional immobilization of bioactive 
molecules on the surface is necessary to induce desired biological activities, e.g. the adsorption of 
specific cells.  
Poly(ethylene glycol) (PEG, synonym with PEO) is widely used as coating material due to its known 
biocompatibility and potential to minimize unspecific protein adsorption.1-4 It has been shown that 
high grafting densities resulting in high surface coverage of the polymer is a determining factor for 
protein resistance of PEG.5, 6 Furthermore it has been predicted that branched polymer architectures 
should be superior compared to linear one for prevention of unspecific protein adsorption.7, 8 Earlier, 
the protein repelling properties of linear and star-shaped PEG using isocyanate-terminated, star-
shaped poly(ethylene-co-propylene) statistical copolymer (NCO-sP(EO-stat-PO)) has been investi-
gated showing the great potential of the NCO-sP(EO-stat-PO) prepolymer for coating applications.9, 10 
Due to the unique reactivity of the isocyanate end-group, this system does not only undergo a self-
condensing reaction during the coating resulting in high surface covering but furthermore offers the 
possibility to immobilize proteins for specific adhesion of cells.11-13 
During the last decade, the synthesis of polyglycidol (PG) has gained growing interest as they fulfill all 
structural prerequisites to replace star-shaped PEG in biomedical applications.14 In addition, 
polyglycidols are highly functional due to the hydroxymethyl side group, highly biocompatible and 
soluble in aqueous media.14-17 It was shown that polyglycidols as well as their esters have no 
influence on the metabolism as they are assimilated and eliminated rapidly from the body without 
being catabolised.18-22 Several groups have studied the so-called ring-opening multibranching 
polymerization of non-protected glycidol leading to highly branched structures.15, 23-26 These dendritic 
structures have gained much interest during the last years due to their globular structure and their 
usage in biomedical applications have recently been reviewed.27 Furthermore, it has been shown that 
dendritic polyglycidol derivates assembled on gold surfaces resists the unspecific protein 
adsorption.28 
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In general, the microstructure of hyperbranched polyglycidols is not well controlled. To obtain 
structurally well defined polyglycidols with narrow distribution, the hydroxy group of the monomer 
has to be protected by a suitable protecting group prior to polymerization. Mostly ethoxyethyl 
glycidyl ether (EEGE) has been used for the preparation of PG by anionic polymerization since the 
protecting group can be easily removed by treatment under acidic conditions after polymerization 
leading to polyglycidols with well-defined architecture.14, 29-33 To obtain multifunctional polyglycidols, 
either a combination of protecting groups or the use of polyglycidol as core material followed by 
chemical or enzymatical grafting can be used as shown earlier.34, 35 
To achieve long term stable surface coatings, the deployed hydrogel has to be covalently bond to the 
surface to avoid detachment of the layer with time. For this purpose, the prepolymer has to be 
equipped with a highly reactive end group able to form a covalent bond to the surface. As most 
surface materials can be equipped with amine groups, most groups showing reactivity towards 
amines can be used. The use of an isocyanate group for this purpose has already been mentioned 
earlier showing a high reactivity towards amine-functionalized surfaces compared with self-
condensing abilities.11, 13 Nonetheless, the high reactivity of the isocyanate group can also be con-
sidered as a drawback as the prepolymer is non-stable towards humidity and therefore has to be 
stored under inert atmosphere prior to its usage.  
As a potential alternative to the isocyanate end group, the functionalization of polyglycidols with the 
vinyl sulfonate group and their high reactivity towards different amines compared with stability 
towards humidity and oxygen has been shown in chapter 3 and chapter 4. Either using star-shaped 
poly(ethoxyethyl glycidyl ether) (sPEEGE) or star-shaped polyglycidol (sPG), the conjugation addition 
can be carried out either in organic or aqueous solution under mild conditions offering the possibility 
to work with proteins or peptides.  
In this chapter, the use of vinyl sulfonate terminated, star-shaped polyglycidol as surface coating is 
reported. Films were obtained using spin coating technique and the coatings were studied with 
regard to their homogeneity, ability to resist protein adsorption and the behavior of cells. 
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7.2 Experimental Part 
Materials 
Dimethyl sulfoxide (DMSO), dichloromethane (DCM) and tetrahydrofuran (THF) has been purchased 
in analytical grade over molecular sieve from Sigma-Aldrich and used as received. Dipentaerythritol, 
glycidol, triethylamine, potassium tert.-butoxide (1.0 M in THF), 2-chloroethylsulfonyl chloride and 
(R)-(-)-4-(3-Aminopyrolidino)-7-nitrobenzofuran were purchased from Sigma-Aldrich and used as 
received. EEGE was synthesized according to literature procedure.36 
Polymer synthesis 
The synthesis of the vinyl sulfonate terminated, star-shaped polyglycidol has been described in detail 
in chapter 3. Briefly, sPEEGE has been synthesized using dipentaerythritol as initiator, ethoxyethyl 
glycidyl ether as monomer, potassium tert.-butoxide and DMSO in an anionic polymerization 
procedure. Afterwards, sPEEGE has been reacted with 2-chloroethylsulfonylchloride to obtain vinyl 
sulfonate terminated sPEEGE (VS-sPEEGE). To obtain the non-protected polyglycidol, the protecting 
group has been removed by treatment with hydrochloric acid to achieve vinyl sulfonate terminated 
sPG (VS-sPG). The resulting product has been purified by dialysis against water. Size exclusion 
chromatography proved that no formation of dimmers took place. 
Substrate preparation 
Both glass and Silicon substrates were cut into pieces of approximately 1 x1 cm2. The samples were 
then cleaned through sonication in acetone, Millipore water and isopropanol for one minute each. 
After drying in a stream of nitrogen, the samples were activated by treatment with UV/ozone for 12 
minutes, and then aminosilanized in gas phase using 100 µL of N-[3-(trimethoxysilyl)propyl]-
ethylenediamine. The substrates were then used immediately for spin coating. 
Spin coating 
The spin coating solution was prepared by dissolving either 100 mg of VS-sPEEGE in 10 mL THF or by 
dissolving either 500 or 100 mg VS-sPG in 9.95 mL of Millipore water and 0.05 mL Et3N depending on 
the desired concentration. The solutions were usually used immediately after preparation, but can be 
stored at room temperature for days without loose of reactivity. For spin coating, the samples were 
placed on the spin coater, covered by the filtered solution and then accelerated within 5 s to 
2,500 rpm for 40 s. Afterwards, samples coated with VS-sPG were incubated in H2O for one hour 
while samples coated with VS-sPEEGE were incubated in THF for one hour to remove excess polymer 
and then dried under a steam of nitrogen. 
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Cleavage of acetal group 
To cleave the acetal protecting group of VS-sPEEGE coated samples, they were incubated for 2 hours 
in a solution of 5 mL hydrochloric acid and 45 mL H2O. Afterwards, the samples were incubated in 
H2O for another hour to remove remaining polymer fragments and then dried under a steam of 
nitrogen resulting in VS-sPG coated samples as well. 
Contact angle measurement 
Contact angle were determined by sessile drop measurements with a geniometer G40 (Krüss, 
Hamburg, Germany). The resulting value of each single measurement is the average value of the left 
and the right contact angle. For each sample, 3 droplets had been measured for determination of the 
contact angle. The presented data are the average values of the measurements. Errors were 
determined through evaluation of the standard derivation of the measurements. 
Fluorescence microscopy 
Fluorescence microscopy was performed using an Axioplan2 Imaging microscope (Zeiss) combined 
with an N XBO 75 lamp (Zeiss) and the Zeiss fluorescence filter set 31, and pictures were taken with a 
Princeton Instruments NTE/CCD 512EBFT camera with different irradiation times. 
X-ray photoelectron spectroscopy (XPS) analysis 
XPS analysis was performed using an X-Probe 206 spectrometer (Surface Science Instruments, USA). 
An aluminum anode was used as X-ray source. The binding energies were referenced to hydrocarbon 
at 285.0 eV. The emission angle of electrons was set at 55° with respect to the sample normal, which 
results in an information dept of 10 nm. 
Scanning force microscopy (SFM) 
Scanning force microscopy was performed with a Nanoscope III (Digital Instruments) microscope. 
Investigations in the tapping mode were carried out with Si-cantilevers (Nanosensors) with a spring 
constant of approximately 50 N m-1 and a tapping frequency around 350 kHz. Images were edited 
with Nanoscope software (v5.12r5). 
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7.3 Results and Discussion 
In general, two different pathways are possible to achieve a hydrogel coating based on vinyl 
sulfonate terminated, star shaped polyglycidol as shown in Figure 7-1. 
 
Figure 7-1: General approach for surface coating and further functionalization. 
The polyglycidol hydrogel layer can be applied to an amine functionalized surface either by spin 
coating of VS-sPG from aqueous solution or by spin-coating of VS-sPEEGE from an organic solution 
followed by removal of the acetal group by treatment with hydrochloric acid. Furthermore, 
remaining non-reacted vinyl sulfonate groups on the surface can be used for further immobilization 
of bioactive compounds to control the surface properties. 
In the first part of this chapter, the difference between the two different coating possibilities is 
discussed. Afterwards, the films were characterized in detail with regard to their homogeneity and 
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their ability to resist protein adsorption. Finally the cell behavior on the surface of the samples is 
reported. 
7.3.1 Influence of the coating procedure 
Silicon substrates were activated by treatment with UV/Ozone, aminosilanized using N-[3-(tri-
methoxysilyl)propyl]ethylenediamine and then coated by spin-coating of either a solution of 10 
mg mL-1 VS-sPEEGE in THF or 10 mg mL-1 VS-sPG in water. Afterwards, the acetal group of the VS-
sPEEGE coated samples was removed by treatment with hydrochloric acid and then the 
hydrophilicity of all three different sample types has been determined by contact angle 
measurements as shown in Figure 7-2 and Figure 7-3. 
 
Figure 7-2: Measurement of the contact angle of an aminosilanized Silica wafer (1), a VS-sPEEGE coated sample (2), a VS-
sPG coated sample derived from VS-sPEEGE and acetal cleavage (3) and a VS-sPG coated sample achieved by direct 
application of VS-sPG (4). 
 
Figure 7-3: Drop shape of an aminosilanized Silica wafer (1), a VS-sPEEGE coated sample (2), a VS-sPG coated sample 
derived from VS-sPEEGE and acetal cleavage (3) and a VS-sPG coated sample achieved by direct application of VS-sPG (4). 
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As seen by the contact angle measurements, no significant difference of the hydrophilicity of the 
surface coated either directly with VS-sPG or by two-step process could be observed indicating the 
compete removal of the acetal group. For further validation, the applied hydrogel coatings have been 
further examined by X-ray photoelectron spectroscopy (XPS) as summarized in Table 7-1. 
Table 7-1: XPS-analysis data of an aminosilanized Silica wafer (1), a VS-sPEEGE coated sample (2), a VS-sPG coated sample 
derived from VS-sPEEGE and acetal cleavage (3) and a VS-sPG coated sample achieved by direct application of VS-sPG (4). 
Silicon not shown here and values are calculated to 100%. n.d. = not detectable. 
 1 2 3 4 
 atom% atom% atom% atom% 
Oxygen 29 33 46 44 
Nitrogen 12 2 5 3 
Carbon 59 62 44 50 
Sulfur n.d. 3 5 3 
 
Similar to the results obtained by contact angle measurements, no significant difference could be 
observed for samples coated either directly from aqueous solution (4) or by the two-step process (3). 
Compared to the theoretical values (38 atom% oxygen:41 atom% carbon for VS-sPG), both samples 
showed higher amounts of both oxygen and carbon. Furthermore, all samples still showed a 
significant amount of silicon signal (not shown in the table) indicating that not only the hydrogel 
coating but also the surface of the samples has been observed by the XPS measurements. This is a 
clear indication for either a less than 10 nm thick hydrogel layer or a not completely coverage of the 
surface. None the less, as no significant difference between the two coating methods was observed, 
therefore results of samples obtained by either method should be comparable. 
7.3.2 Chemical vs. physical adsorption 
It is a known fact for various kinds of polymers that they may bind strongly to a surface by physically 
interactions. However, it is very important, especially for biomedical applications, to know whether 
the polymer binds only physically or as well chemically to a surface as the type of the bond strongly 
influences the long term stability of the coating. For differentiation between physically and 
chemically adsorption of sPEEGE on a surface, amine functionalized silica wafer were coated with 
non-functionalized sPEEGE which only absorbs physically on the surface of the samples. For 
comparison, samples were coated with VS-sPEEGE which can absorb both physically and chemically 
to the surface. Afterwards, the hydrophilicity of the two different sample types was determined by 
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measurement of the contact angle prior and after 24 h incubation in THF. As sPEEGE is easily soluble 
in organic solvents, treatment with THF should remove any polymer not covalently bond to the 
surface. The results of the measurements are summarized in Figure 7-4. 
 
Figure 7-4: Measurement of the contact angle of sPEEGE and VS-sPEEGE (2) coated samples prior and after 24 hours 
incubation in THF. 
No significant difference of the contact angle could be observed comparing non-functionalized and 
VS-functionalized sPEEGE coated samples representing a strong physical adsorption of the polymer 
on the surface. None the less, after 24 hours incubation in THF samples coated by non-functionalized 
sPEEGE showed a high contact angle comparable to those of non-coated Si wafer. However, samples 
coated by VS-sPEEGE showed even higher hydrophilicity after incubation compared to 
measurements directly after the coating procedure. This shows clearly that no loss of the hydrogel 
layer occurred and that covalent bonding on the aminosilanized surface took place using vinyl 
sulfonate terminated polyglycidol. 
 
7.3.3 Characterization of the hydrogel layer 
For the usage of a polymer coating for biomedical applications, it is important that the polymer forms 
a homogeneous layer on the surface of the sample. As shown in Figure 7-5, investigations by 
scanning force microscopy showed a smooth polymer coating on the surface of the silicon substrate. 
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Figure 7-5: SFM pictures of the surface of an aminosilanized Si wafer (upper left), a sample coated with 10 mg mL
-1
 VS-sPG 
(lower left) and a sample coated with 50 mg mL
-1
 VS-sPG (lower right). 
While the aminosilanized silicon surface does not show any intrinsic structure, the hydrogel layer can 
be easily indentified on the SFM pictures of both coated surfaces. Samples coated with 10 mg mL-1 
VS-sPG showed a very homogeneous but thin hydrogel layer as seen in the lower left picture of 
Figure 7-5. Coating of samples with a higher concentration led to a thicker but more inhomogeneous 
coating. However, contact angle measurements showed that samples coated with 50 mg mL-1 VS-sPG 
showed an increased hydrophilicity compared to samples coated with lower amounts of VS-sPG. 
Therefore, coatings derived from both concentrations will be further tested. 
For the use within biological systems, the potential of the applied polymer coating to minimize the 
unspecific protein adsorption is of great interest. It has already been shown in chapter 6 that VS-
sPEEGE can decrease the adsorption of proteins dramatically compared to hydrophobic polymers, 
e.g. PCL. Therefore, coatings based on sPG are expected to decrease the protein adsorption even 
more due to the higher hydrophilicity of the polymer after the cleavage of the acetal group. For 
investigation of the protein repelling properties, samples coated with either VS-sPEEGE or VS-sPG 
were incubated with fluorescently labeled BSA, washed several times and remaining adsorbed BSA 
had been detected by fluorescent microscopy as shown in Figure 7-6. 
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Figure 7-6: Fluorescent images of an aminosilanized (upper left), a VS-sPEEGE coated (upper right) and a VS-sPG coated 
(lower) silicon substrate after incubation in fluorescently marked BSA. 
As expected from previous results shown in chapter 6, samples coated with VS-sPEEGE showed a 
strongly decreased protein adsorption compared to non-coated samples. However, samples coated 
with VS-sPG showed an increased protein adsorption compared to samples coated by VS-sPEEGE. 
This is unexpected as these samples showed higher hydrophilicity as determined by contact angle 
measurements as reported in section 7.3.1. One potential explanation for these results could be a 
non-consistent hydrogel layer. In contrast to the well established NCO-sP(EO-stat-PO) system, the 
VS-sPG system cannot undergo self-condensing; therefore it is possible that the hydrogel layer is 
either to thin or not dense enough to completely suppress the protein adsorption. Another potential 
explanation for the higher protein adsorption in VS-sPG coated surface compared to VS-sPEEGE 
coated ones could be the possibility of hydrogen bonding between the free OH-groups of the 
polymer and the protein. As shown earlier by Ostuni et al., protein adsorption does not necessarily 
correspond with the hydrophilicity of the surface.3 Furthermore, it has been shown that elimination 
of hydrogen bond donor groups appears to be a key structural element in protein-resistant 
properties.37 As these former results are in good agreement with the recent results presented here, 
hydrogen bonding appears to be an important issue here as well explaining the better results for VS-
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sPEEGE despite the lower hydrophilicity. To prove these assumptions, further investigations with 
different polyglycidol derivates have to be made to ensure a relation between the free hydroxy 
groups and the protein adsorption. 
7.3.4 Cell behavior 
For the usage of hydrogel coatings in biomedical applications, the behavior of cells on the interface is 
of great importance. It is known that hydrophilic coatings can successfully suppress the adhesion of 
cells on the surface.12, 13 
Therefore, the growth of cells on both VS-sPEEGE and VS-sPG coated samples has been determined 
in this last section of this chapter. For investigation of the cell behavior, human dermal fibroblast 
(HDF) cells were seeded on both coated and non-coated glass substrates and then let grown for 24 
hours. Afterwards, the cell behavior was determined by optical microscopy as shown in Figure 7-7. 
 
Figure 7-7: Optical microscope image of HDF cells after 24 hours growth time on VS-sPEEGE (left) and VS-sPG (right) coated 
glass substrates. 
Cells grown on either type of coated substrates showed good adhesion and proliferation. This is 
remarkable as the hydrophilicity of the two different substrates heavily differs as shown in 7.3.1 
which normally influences strongly the adhesion of cells on the interface. For further investigations, 
the viability of the cells was determined by a life-dead assay. Results of this assay are shown in Figure 
7-8. 
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Figure 7-8: Life-dead assay of HDF cells on VS-sPEEGE (left) or VS-sPG (right) coated glass substrates after 48 h growth time. 
For both surface coatings, almost no dead cells were detected. Therefore, both surface coatings can 
be determined as non-cytotoxic. None the less, no influence of the polymer on the growth of the 
cells can be detected indicating an either incomplete or thin coating. For a detailed description of the 
influence of either VS-sPG or VS-sPEEGE based coatings, further investigations have to be made. 
 
7.4 Conclusion 
Hydrogel coatings based on vinyl sulfonate terminated, star shaped polyglycidol can be applied to 
amine-functionalized surfaces via two different pathways: (i) by coating of the surface with VS-
sPEEGE from organic solutions followed by removal of the acetal group or (ii) by coating of the 
surface with VS-sPG from aqueous solutions. Detailed investigation of the resulting hydrogel layers 
showed no significant difference between the coatings derived by either pathway indicating that 
both methods are suitable for surface coating. Furthermore, covalent bonding between the applied 
hydrogel layer and the surface occurred by conjugation addition reaction as indicated by stability 
tests. 
Investigation of the hydrogel coating by SFM showed homogeneous layers depending on the 
concentration of the coating solution. Furthermore, investigation of the protein repelling properties 
of the coatings showed almost no unspecific protein adsorption for layers based on VS-sPEEGE. 
Despite the fact that coatings based on VS-sPG are way more hydrophilic than VS-sPEEGE based 
coatings, VS-sPG coatings showed increased protein adsorption on the surface. Finally, cell growth 
experiments showed no significant influence of VS-sPG based coatings on the behavior of cells. 
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8.1 Introduction 
In chapter 7, first results for the use of vinyl sulfonate terminated, star-shaped polyglycidols as a new 
coating system are reported. None the less, further investigations have to be made prior to use of 
VS-sPG in coating applications. Therefore, the established system based on isocyanate terminated 
poly(ethylene glycol) was used within this chapter for the development of novel wound dressings 
with superior properties. 
Nowadays, modern wound dressings are not only applied to cover wounds but also to promote their 
healing process. During the last decades, the wound healing process as well as the influence of 
external effects has been investigated in detail.1, 2 Especially for chronic and burn wounds, cotton and 
viscous gauze dressings have been replaced due to the negative effects on the wound healing 
process as well as the caused trauma during the change of the dressings. Beside their easy 
changeability, ideal wound dressings should also be able to maintain a moist environment, to remove 
excess exudates, to protect the wound from micro-organisms as well as to provide mechanical 
protection. Furthermore, cost efficiency is another important point.3 Modern wound dressings based 
on hydrogel materials, e.g. alginate, combined with antimicrobial materials, e.g. silver, fulfill most of 
the requirements, but often show a lack of mechanical stability.4-6 Furthermore, due to the need of 
expensive components, high costs are a major drawback for some applications as well. 
To combine the outstanding wound healing properties of hydrogel coatings with the mechanical 
properties of viscous cotton dressings, the potential of hydrogel-coated cellulose nonwovens for 
wound dressing applications will be investigated. Hydrogel coatings based on isocyanate-terminated, 
star-shaped copolymers containing poly(ethylene oxide) and poly(propylene oxide) (NCO-sP(EO-stat-
PO)) on different surfaces have been investigated during the last years.7-9 It had been shown that the 
hydrogel layer tremendously suppresses the unspecific protein adsorption due to the increase of the 
hydrophilicity of the surface.10, 11 Therefore, the anti-adhesive properties of the hydrogel coating 
seem to be promising to reduce the adhesion on macromolecular scale. 
To minimize bacterial growth on the surface, further functionalization of the coating is necessairy.12 
Silver as well as ionic silver (Ag+) is frequently used in medical applications due to the high 
antimicrobial effect on various kind of bacteria.5, 13, 14 As a drawback, high doses of silver does not 
only affect the growth of microorganisms, but also the growth of cells and therefore interferes with 
an ideal wound healing process.13 
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To support the wound healing process, the growth of different cell types, e.g. fibroblasts or 
endothelial cells, has to be accelerated. Nitric oxide (NO) was identified to promote angiogenesis and 
had been shown to stimulate cell growth.15-17 Furthermore, arginine has been identified as a 
physiological precursor of nitric oxide in the extracellular matrix.18, 19 Therefore, it is expected that 
the release of arginine from the wound dressings will lead to an improvement of wound healing 
process. 
Within this chapter, the coating of cellulose nonwovens, their adhesion on surfaces as well, the 
equipment of the hydrogel layer with silver nanoparticles for the minimization of the bacterial 
growth will be presented. Furthermore, loading and release of arginine to support the wound healing 
process will be described as well. 
 
  
Chapter 8: Nonadhesive, Antibacterial Wound Dressings 
105 
8.2 Experimental Part 
Materials 
Zemuko® cellulose wound dressings were provided by Lohmann&Rauscher GmbH, Neuwied, 
Germany. Tetrahydrofuran (THF), n-hexane, ethanol, phosphate buffered saline (PBS) and arginine 
has been purchased from Sigma-Aldrich Chemie GmbH, Taufkirchen, Germany and has been used as 
received. Trisodium citrate (TNC) has been purchase from Riedel- de Haen, Seelze, Germany, silver 
nitrate from Merck, Darmstadt, Germany. Tetramethylred-labeled bovine serum albumin (BSA) was 
purchased from Invitrogen, Darmstadt, Germany. NCO-sP(EO-stat-PO) has been synthesized 
according to literature.20 All other chemicals were purchased from different suppliers at high quality. 
Coating procedure 
The top layer of the Zemuko® cellulose wound dressing has been removed and extracted 2 h with a 
solution of n-hexane and ethanol (79:21 v/v). After drying overnight, the nonwoven was activated by 
treatment with ammonia plasma at 400 W and 0.4 mbar for 4 min.  
For application of the hydrogel layers, 10 mg NCO-sP(EO-stat-PO) per mL coating solution was 
dissolved in THF:water (1:9 v/v) and then the activated nonwoven has been immersed in the solution 
for 5 min. Afterwards, the nonwoven were dried for 1 h. To apply several hydrogel layers, dip-coating 
followed by drying was repeated several times. After the last hydrogel coating step, the nonwoven 
was dried overnight. 
 
Generation of silver nanoparticles 
Silver nanoparticles were synthesized according to established procedures. Briefly, 10 mg silver 
nitrate was dissolved in 2.3 mL water and mixed with a solution of 47 mg trisodium citrate in 2 mL 
H2O. Afterwards, a fresh solution of 3.3 mg sodium borohydride solution and 47 mg trisodium citrate 
in 2 mL H2O was added and the mixture let stirred for 15 min resulting in a solution with 1 mg mL
-1 
silver nanoparticles. The successful synthesis of silver nanoparticles was verified UV-VIS 
spectroscopy. 
Incorporation of silver nanoparticles in the hydrogel layer 
For the incorporation of silver nanoparticles in the hydrogel layer, the first four coating steps were 
carried out as described. For the last step, between 0.05 mL (for 0.5 wt.%) and 0.3 mL (for 3 wt.%) of 
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the water used for the coating solution was replaced by the corresponding amount of the silver 
nanoparticle solution resulting in 0.05 to 0.3 mg silver nanoparticles embedded in the hydrogel layer. 
Incorporation of arginine 
For the loading with arginine, the nonwovens were coated five times as described previously. 
Afterwards, they were incubated in a solution of either 250 µg mL-1, 500 µg mL-1 or 1 mg mL-1 
arginine in water for 30 min and then dried at room temperature. 
Unspecific protein adsorption 
For the determination of the unspecific protein adsorption, samples with approx. 1 x 1 cm2 were 
prepared and coated as previously described. After incubation of the samples in a solution of 
50 µg mL-1 tetramethylrhodamine-labeled bovine serum albumin in PBS for 20 min, the samples were 
washed twice with PBS and twice with water. Afterwards, remaining protein was detected using a 
fluorescent microscope (Axioplan 2 Imaging, Zeiss, Oberkochen, Germany). As reference, uncoated 
nonwovens were treated in similar manner. 
Determination of the adhesion power 
The measurements were conducted by Lohmann&Rauscher GmbH, Neuwied, Germany. 
To quantify the adhesion of coated and uncoated wound dressings, samples with approx. 2 x 15 cm2 
were prepared and coated as previously described. To determine the adhesion on a surface, the 
samples were glued to a glass plate using an 8 wt.% gelatin in water solution and then let dried for 4 
h at 60 °C followed by drying overnight at room temperature. Afterwards, the required force for the 
removal of the samples from the surface was determined using a tensile testing machine. For each 
type, 10 samples were measured and the average has been determined. As reference, uncoated 
nonwovens were treated in similar manner.  
Cytotoxicity assay 
The measurements were conducted at the Department of Plastic Surgery, Hand and Burns Surgery of 
the University Hospital Aachen. 
To exclude the release of toxic compounds from the hydrogel coated nonwovens, the influence of 
the eluate on the growth of human fibroblasts was determined. After seeding of 300 000 human 
fibroblast cells in RPMI1640 medium containing 10% FCS in a six well plate and incubation for 3 hours 
at 37 °C, coated and uncoated nonwovens (approx. 1 x 1 cm2) were added to the medium and 
incubated for 24 h resp. 48 h. Afterwards, the culture medium as well as the nonwoven was removed 
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followed by addition of 500 µL new culture medium and 50 µL Alamarblue and incubation was 
continued for another 2 h at 37 °C. 2x100 µL of the medium were transferred to a 96 well plate and 
fluorescence of the samples was measured using an Optima Fluorescence Reader at 544 nm. As 
reference, the influence of tissue culture polystyrene (TCPS) on the growth of fibroblasts has been 
determined. 
Expression of Interleukin 1-β (IL-1β), Tumor Necrosis Factor 1-α (TNF-α) and Interleukin 8 (IL-8) 
The measurements were conducted at the Department of Plastic Surgery, Hand and Burns Surgery of 
the University Hospital Aachen. 
To determine a potential inflammatory response upon contact with hydrogel coated nonwovens, 
500 000 cells of the human macrophage cell line THP1 were incubated with coated nonwovens for 24 
h. Afterwards, the secretion of IL-1β, TNF-α and IL-8 was determined by a specific ELISA (R&D 
System). As reference, the secretion was determined after contact with TCPS. 
Influence of arginine on the cell growth 
The measurements were conducted at the Department of Plastic Surgery, Hand and Burns Surgery of 
the University Hospital Aachen. 
To determine the influence of arginine released by hydrogel coated nonwovens, 15 000 to 50 000 
human fibroblasts, keratinocytes or rat endothelial cells were seeded in arginine free, specific culture 
medium in a 6 well plate. After incubation for 3 h at 37 °C, hydrogel coated nonwovens loaded with 
different amounts of arginine were incubated with the cells for up to 11 days. For the measurement 
of the proliferation, the culture mediums as well as the nonwoven were removed followed by 
addition of 500 µL new culture medium and 50 µL Alamarblue and incubation was continued for 
another 2 h at 37 °C. 2 x 100 µL of the medium were transferred to a 96 well plate and fluorescence 
of the samples was measured using an Optima Fluorescence Reader at 544 nm. As reference, the 
influence of tissue culture polystyrene (TCPS) on the growth of fibroblasts has been determined. 
Antibacterial properties 
For the determination of the antibacterial properties of the nonwoven with embedded silver 
nanoparticles, 100 000 E.coli bacteria in 50 µL culture medium were incubated with hydrogel coated 
nonwoven loaded with either 0.5 wt.%, 1 wt.%, 1.5 wt.%, 2 wt.% or 3 wt.% silver nanoparticles. After 
2.5 h incubation at 25 °C and 90 % humidity, 1 mL culture medium was added and the samples were 
shaken for 30 min at room temperature and 150 rpm. Afterwards, 2 x 200 µL medium were 
transferred in a well plate and incubated for 20 h at 37 °C and 100 rpm. The growth of the bacteria 
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was monitored using a micro plate reader GENios Pro, Tecan, Männedorf, Switzerland by 
determination of the optical density at a wavelength of 612 nm (OD612). 
 
8.3 Results & Discussion 
In the first part of this chapter, the equipment of a cellulose nonwoven with a hydrogel layer to 
minimize the adhesion on the wound was under investigation. Furthermore, the influence of the 
hydrogel on the growth of cells will be shown. In the second part the influence of arginine released 
from the hydrogel layer on the wound healing process has been investigated. In the last part the 
hydrogel layers were additionally equipped with silver particles to achieve antibacterial properties. 
 
8.3.1 Reduction of the adhesion by hydrogel coating 
To minimize the adhesion of a cellulose wound dressing, the nonwoven was activated by treatment 
with ammonium plasma followed by dip-coating in a solution of NCO-sP(EO-stat-PO) dissolved in a 
mixture of THF and water. As shown in Figure 8-1, the nonwovens were investigated by electron 
microscopy after one, three or five consecutive coating steps. 
 
 
Figure 8-1: Electron microscope pictures of cellulose nonwovens prior (A) and after one (B), three (C) and five (D) 
consecutive dip coating steps. 
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Repeat of the dip-coating procedure led to an increased thickness of the hydrogel layer. After a single 
hydrogel coating step the cellulose fibers appear smoother due to the hydrogel layer (Figure 8-1:A) 
compared to uncoated ones (Figure 8-1:B). After multiple coating steps, the hydrogel started to fill in 
the gaps between the fibers (Figure 8-1:C+D). 
The protein repelling properties of the hydrogel coated nonwovens were determined by incubation 
of the nonwovens in a solution of fluorescently labeled bovine serum albumin in PBS, followed by 
detection of the fluorescence of the adsorbed protein by fluorescent microscopy as seen in Figure 8-
2. 
 
Figure 8-2: Fluorescence microscope pictures of cellulose nonwovens prior (A) and after one (B), three (C) and five (D) 
consecutive dip coating steps followed by incubation in tetramethylrhodamin-labelled bovine serum albumin. 
Despite the different thickness of the coatings after one or multiple coating steps, no fluorescence 
was detected on all coated samples. Therefore, all coated nonwovens effectively suppress the 
unspecific adsorption compared to an uncoated sample (Figure 8-2:A). 
To analyze the potential of the hydrogel coating layer to reduce the adhesion, the adhesion power of 
both coated and uncoated nonwovens was determined by Lohmann&Rauscher GmbH, Neuwied. For 
quantification of the adhesion power of the samples on the surface, different coated and uncoated 
samples were glued to a surface by gelatin and then the force needed to remove the samples was 
determined using a tensile testing machine. The results are summarized in Figure 8-3. 
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Figure 8-3: Measurement of the adhesion power of coated and non-coated nonwovens using a simulated wound model by 
Lohmann&Rauscher GmbH, Neuwied, Germany. 
Already a thin hydrogel layer applied by one dip coating step is able to decrease the force for 
removal of the nonwoven from a surface to 5% compared to uncoated ones. The slightly thicker 
hydrogel layer applied by five consecutive dip coatings steps further decreases the adhesion to 
approximately 2%. These results show the high potential of hydrogel coated cellulose nonwovens for 
the application as non-adhesive wound dressings. 
Furthermore, a coated cellulose nonwoven could be removed residue-free from a surface in contrast 
to uncoated or activated as shown in Figure 8-4. 
 
Figure 8-4: Residue of non-coated (right), plasma-activated (left) or 5x hydrogel-coated (middle) nonwovens after 
determination of the adhesion power. Figure provided by courtesy of Lohmann & Rauscher GmbH, Neuwied, Germany. 
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8.3.2 Influence of Hydrogel Coated Wound Dressings on Cell Growth and Inflammation Risk 
Cellulose nonwovens are known to be highly biocompatible and are widely used as wound dressings. 
Furthermore, the hydrogel system based on NCO-sP(EO-stat-PO) is known to be highly biocompatible 
as well, but to ensure the biocompatibility of the modified nonwovens, the influence of both coated 
and uncoated wound dressings on the growth of human fibroblasts was investigated by incubation of 
the samples within the cell medium during the growth for 24 h resp. 48 h. The results of the growth 
test are shown in Figure 8-5. 
 
Figure 8-5: Relative cell count of human fibroblasts 0 h, 24 h and 48 h after contact with uncoated, one time and five time 
coated nonwovens. Figure provided by courtesy of Prof. Dr. Christoph Suschek. 
Neither pure nor coated nonwovens show any significant effect on the growth of the cells indicating 
the high biocompatibility of the coated samples. Additionally, the risk of inflammation reaction 
caused by the coated nonwoven was investigated by determination of the expression of different 
inflammatory cytokines by an ELISA essay. The results of the essay are summarized in Figure 8-6. 
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Figure 8-6: Determination of the secretion of the cytokines IL-1β and TNF-α as well as the chemokine IL-8 after contact with 
five time hydrogel-coated nonwovens compared to tissue cultured polystyrene (TCPS) by specific ELISA essay. Figure 
provided by courtesy of Prof. Dr. Christoph Suschek. 
After contact with hydrogel-coated nonwovens, neither the secretion of the cytokine Interleukin 1-β 
(IL-1β) nor Tumor Necrosis Factor 1-α (TNF-α), both indicating an inflammation, was increased. This 
clearly shows that no inflammation reaction was induced by the contact of the hydrogel layer with 
cells. The significant increase of the secretion of the chemokine Interleukin 8 (IL-8) will not lead to an 
inflammation reaction as it only attracts macrophages but not activates an inflammatory process and 
therefore is not a major drawback for the desired application as wound dressing. 
8.3.3 Incorporation of Wound Healing Supporting Molecules 
To support the wound healing process, arginine can be used for the in-situ formation of nitric oxide 
which supports tissue formation. Therefore, equipment of the hydrogel layer with arginine should 
accelerate the cell growth during contact with loaded, hydrogel-coated nonwovens. For the 
determination of this effect, hydrogel coated nonwovens were prepared and loaded with different 
amounts of arginine (250-1000 µg mL-1) by dip coating. Afterwards, fibroblast, keratinocytes and 
endothelial cells were incubated together with loaded nonwovens for up to 11 days and then the cell 
growth was determined. In Figure 8-7, the relative cell count is shown in relation to a control samples 
without arginine. 
Chapter 8: Nonadhesive, Antibacterial Wound Dressings 
113 
 
Figure 8-7: Relative cell count of fibroblasts, keratinocytes and endothelial cells after 10 days upon contact with arginine 
loaded, hydrogel coated nonwovens. Figure provided by courtesy of Prof. Dr. Christoph Suschek. 
It can be clearly seen that loading of different amounts of arginine into the hydrogel layer followed 
by subsequent release during the incubation led to an increased growth of all cell types. Nonwovens 
incubated with 1000 µg mL-1 arginine showed the best results while nonwovens incubated with 250 
or 500 µg mL-1 showed less cell growth compared to samples with 1000 µg mL-1, but still accelerated 
cell growth compared to non-loaded wound dressings. 
8.3.4 Antimicrobial Equipment of Wound Dressings 
Infection of a wound by bacteria is one of the most frequent complications during the wound healing 
process. To overcome this problem, hydrogel coated nonwovens were equipped with silver 
nanoparticles generated by chemical reduction of silver nitrate. To load the hydrogel layer, silver 
particles were mixed with the hydrogel coating solution. The distribution of nanoparticles inside the 
hydrogel layer was determined by electron microscopy as shown in Figure 8-8. 
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Figure 8-8: FESEM pictures of a hydrogel coated nonwoven loaded with 3 wt.% silver nanoparticles. 
The nanoparticles were uniformly distributed over the coated cellulose fiber. Furthermore, the 
antimicrobial activity of the embedded silver nanoparticles was evaluated. To determine the 
antimicrobial efficiency of the nanoparticles in relation to their quantities, different amounts (0 – 3 
wt.% in relation to the hydrogel) were immobilized and their influence on the growth of E.coli was 
determined (Figure 8-9). 
 
Figure 8-9: Growth of E.coli after contact with hydrogel coated nonwovens loaded with 0-3 wt.% silver nanoparticles. 
Already 0.5 wt.% silver nanoparticles are able to reduce the growth of E.coli significantly compared 
to non-loaded sample. While loading of the hydrogel layer with 1 wt.% respectively 1.5 wt.% silver 
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nanoparticles does further increase the inhibition of the growth of the bacteria, no further effect was 
detected for 2 wt.% and 3 wt.%. Furthermore, higher loading of the hydrogel layer lead to leaching 
during the incubation; therefore an amount of 1 or 1.5 wt.% silver nanoparticles seemed to be an 
ideal concentration to minimize the bacteria growth.  
As a drawback, silver nanoparticles are known not only to be toxic against bacteria but also to 
influence cell growth in higher concentrations.13 Therefore, the growth of human fibroblasts was 
investigated upon contact with hydrogel coated nonwovens with embedded silver nanoparticles 
(Figure 10). 
 
Figure 8-10: Cell growth of human fibroblasts after 24 h after contact with hydrogel loaded nonwovens without and with 
0.5 wt.% respectively 3 wt.% silver nanoparticles. 
No influence on the growth was observed neither for nonwovens loaded with 0.5 wt.% nor for 
nonwovens with 3 wt.% silver nanoparticles indicating no toxic effects of silver nanoparticles in the 
used concentrations. 
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8.4 Conclusion 
Commercial available cellulose wound dressings were successfully equipped with a hydrogel layer 
based on NCO-sP(EO-stat-PO). The hydrogel layers tremendously reduced the adhesion force of 
coated nonwovens on surfaces to 2% – 5% compared to uncoated nonwovens while maintaining the 
mechanical properties of the nonwovens. Therefore, coated nonwovens seem perfectly suitable to 
minimize damage of the surrounding tissue during change of the wound dressings. Additionally, 
equipment of the hydrogel layer with arginine supports the wound healing process by acceleration of 
the cell growth of different kinds of cells. For an antimicrobial equipment of the nonwoven, the 
hydrogel coating was loaded with silver nanoparticles to reduce the growth of E.coli significantly. All 
coated nonwovens were tested in cytotoxicity essays and showed no negative effects on the growth 
of fibroblasts. All results demonstrated the high potential of hydrogel coated, loaded nonwovens for 
wound dressings applications. 
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Biomedical Applications 
 
12/10 – 02/11 Auslandsaufenthalt im Rahmen der Promotion, Department of Molecular 
Chemistry, Graduate School of Engineering, Osaka University, Japan 
 
07/07 – 03/08    Diplomarbeit, Makromolekulare Chemie, Philipps-Universität Marburg 
Thema:  Neue Initiatorsysteme für die ringöffnende Polymerisation 
von cyclischen Estern und vinyl-Monomeren 
 
08/06 – 02/07 Auslandsaufenthalt im Rahmen des Studiums, Department of Chemistry, 
University of British Columbia Vancouver, Kanada 
 
04/05 – 03/08 Hauptstudium der Chemie, Wahlfach Makromolekulare Chemie, Philipps-
Universität Marburg 
 
04/03 – 03/05   Grundstudium der Chemie, Christian-Albrechts-Universität Kiel 
 
Berufserfahrung 
 
Seit 05/13 Business Analyst, HCS Group, Frankfurt/Hamburg/London 
 
01/12 – 05/13 Consultant, Bereich Chemie & Öl, Roland Berger Strategy Consultants GmbH, 
München 
 
10/08 – 11/11 Wissenschaftlicher Mitarbeiter, Institut für Technische und Makromolekulare 
Chemie, RWTH Aachen 
 
05/10 – 06/11 Werkstudent, Bereich Marketing & Sales, Roland Berger Strategy Consultants 
GmbH, Düsseldorf 
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03/08 – 07/08 Intern Consulting, Bereich Energy & Chemicals, Roland Berger Strategy 
Consultants GmbH, München 
 
Schulbildung 
06/02   Abitur 
 
1993 – 2002  Alexander-von-Humboldt-Gymnasium, Konstanz 
 
1989 – 1993  Grundschule, Konstanz-Dettingen 
